<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85542</article-id><article-id pub-id-type="doi">10.7554/eLife.85542</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Pooled genome-wide CRISPR activation screening for rapamycin resistance genes in <italic>Drosophila</italic> cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-300702"><name><surname>Xia</surname><given-names>Baolong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2536-0267</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-73325"><name><surname>Viswanatha</surname><given-names>Raghuvir</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9457-6953</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9774"><name><surname>Hu</surname><given-names>Yanhui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86659"><name><surname>Mohr</surname><given-names>Stephanie E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9639-7708</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-300903"><name><surname>Perrimon</surname><given-names>Norbert</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7542-472X</contrib-id><email>perrimon@genetics.med.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Genetics, Blavatnik Institute, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Drosophila RNAi Screening Center, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ht1xw27</institution-id><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ht1xw27</institution-id><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>04</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e85542</elocation-id><history><date date-type="received" iso-8601-date="2022-12-13"><day>13</day><month>12</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-04-09"><day>09</day><month>04</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-12-10"><day>10</day><month>12</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.12.09.519790"/></event></pub-history><permissions><copyright-statement>© 2023, Xia et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Xia et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85542-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-85542-figures-v1.pdf"/><abstract><p>Loss-of-function and gain-of-function genetic perturbations provide valuable insights into gene function. In <italic>Drosophila</italic> cells, while genome-wide loss-of-function screens have been extensively used to reveal mechanisms of a variety of biological processes, approaches for performing genome-wide gain-of-function screens are still lacking. Here, we describe a pooled CRISPR activation (CRISPRa) screening platform in <italic>Drosophila</italic> cells and apply this method to both focused and genome-wide screens to identify rapamycin resistance genes. The screens identified three genes as novel rapamycin resistance genes: a member of the SLC16 family of monocarboxylate transporters (<italic>CG8468</italic>), a member of the lipocalin protein family (<italic>CG5399</italic>), and a zinc finger C2H2 transcription factor (<italic>CG9932</italic>). Mechanistically, we demonstrate that <italic>CG5399</italic> overexpression activates the RTK-Akt-mTOR signaling pathway and that activation of insulin receptor (InR) by <italic>CG5399</italic> requires cholesterol and clathrin-coated pits at the cell membrane. This study establishes a novel platform for functional genetic studies in <italic>Drosophila</italic> cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>CRISPR activation</kwd><kwd>genetic screening</kwd><kwd>rapamycin resistance gene</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM132087</award-id><principal-award-recipient><name><surname>Mohr</surname><given-names>Stephanie E</given-names></name><name><surname>Perrimon</surname><given-names>Norbert</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CA120964</award-id><principal-award-recipient><name><surname>Perrimon</surname><given-names>Norbert</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Perrimon</surname><given-names>Norbert</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>NIH</institution></institution-wrap></funding-source><award-id>P01CA120964</award-id><principal-award-recipient><name><surname>Perrimon</surname><given-names>Norbert</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A novel genome-wide transcriptional activation screening in <italic>Drosophila</italic> cells revealed the activation of InR-Akt-mTOR pathway by cholesterol in plasma membrane to confer resistance to Rapamycin.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Although <italic>Drosophila</italic> is one of the most intensively studied organisms, about half of <italic>Drosophila</italic> protein-coding genes still lack functional characterization (<xref ref-type="bibr" rid="bib11">Ewen-Campen et al., 2017</xref>). Genome-scale loss-of-function (LOF) and gain-of-function (GOF) genetic perturbations facilitate functional genomic studies. In <italic>Drosophila</italic>, genome-wide LOF screens using RNA interference or CRISPR-Cas9 have helped elucidate the mechanisms of a variety of biological processes (<xref ref-type="bibr" rid="bib3">Boutros et al., 2004</xref>; <xref ref-type="bibr" rid="bib2">Björklund et al., 2006</xref>; <xref ref-type="bibr" rid="bib9">D’Ambrosio and Vale, 2010</xref>; <xref ref-type="bibr" rid="bib1">Bard et al., 2006</xref>; <xref ref-type="bibr" rid="bib12">Guo et al., 2008</xref>; <xref ref-type="bibr" rid="bib14">Hao et al., 2008</xref>; <xref ref-type="bibr" rid="bib33">Song et al., 2022</xref>; <xref ref-type="bibr" rid="bib38">Viswanatha et al., 2018</xref>). However, genome-wide GOF screens have not been feasible, largely due to a lack of the reagents for genome-scale GOF perturbation. Current state-of-the-art for <italic>Drosophila</italic> GOF studies utilizes cDNA library overexpression (<xref ref-type="bibr" rid="bib35">Stapleton et al., 2002</xref>; <xref ref-type="bibr" rid="bib41">Yu et al., 2011</xref>), which only covers a subset of the genome and underrepresents genes with long open reading frames (ORFs).</p><p>CRISPRa is a complementary approach for GOF studies. Nuclease-dead Cas9 (dCas9) is fused with different transcriptional activators and targeted to the promoter region by single-guide RNAs (sgRNAs) to facilitate transcription at endogenous loci. Synergistic activation mediator (SAM) complex is one of the most efficient CRISPRa systems (<xref ref-type="bibr" rid="bib17">Konermann et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Chavez et al., 2016</xref>). With the SAM system, synthetic transcriptional activators dCas9-VP64 and MCP-p65-HSF1 are recruited to the promoter region of endogenous genes by MS2 hairpin-containing sgRNAs. Genome-scale perturbation with CRISPRa can be achieved by synthesizing a genome-wide sgRNA library, bypassing the need to generate a genome-wide ORF library. CRISPR-based GOF approaches have been used for genome-wide genetic screens in mammalian cells (<xref ref-type="bibr" rid="bib17">Konermann et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Rodríguez et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">Zhu et al., 2022</xref>; <xref ref-type="bibr" rid="bib32">Sofer et al., 2022</xref>; <xref ref-type="bibr" rid="bib42">Zhang et al., 2022</xref>), but the feasibility has not yet been tested in <italic>Drosophila</italic> cells.</p><p>To address this gap, we developed a pooled genome-wide CRISPRa screening platform in <italic>Drosophila</italic> cells using the SAM complex. To demonstrate the feasibility of this platform, we performed focused and genome-wide CRISPRa screens and identified novel candidates conferring rapamycin resistance. Next, we focused on one of the top candidates, a member of the lipocalin protein family (<italic>CG5399</italic>), and demonstrate that it positively regulates the Receptor Tyrosine Kinase (RTK)-Akt-mTOR signaling pathway by regulating cholesterol and clathrin-coated pits at the cell membrane.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Inducible CRISPRa using the SAM complex in <italic>Drosophila</italic> S2R+ cells</title><p>To establish CRISPRa in <italic>Drosophila</italic> cells in an inducible manner, the synthetic transcriptional activators of the SAM complex (dCas9-VP64 and MCP-p65-HSF1) were placed under a metallothionein promoter, which can be induced in the presence of copper ions. VP64, p65, and HSF1 are transcriptional activators while the MS2 coat protein (MCP) recognizes and binds to MS2 hairpins present in the sgRNAs, recruiting the fused transcriptional activators to gene promoters targeted by sgRNAs. In addition, the MS2 hairpin-containing sgRNA was expressed from a separate plasmid under the control of the U6 promoter (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). To determine whether this system can mediate transcriptional activation in <italic>Drosophila</italic> cells, plasmids with sgRNAs targeting the promoter regions of <italic>Jon25Biii</italic> or <italic>Sdr</italic> were transfected into <italic>Drosophila</italic> S2<italic>R</italic>+ cells stably expressing the metallothionein promoter-driven SAM complex. Without copper induction, sgRNAs moderately activated the target genes, likely due to leaky expression of the SAM complex from the metallothionein promoter. In the presence of copper, sgRNAs robustly upregulated the target genes (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), showing that the SAM complex is able to mediate gene activation in <italic>Drosophila</italic> S2<italic>R</italic>+ cells.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Inducible transcriptional activation by the synergistic activation mediator (SAM) complex in <italic>Drosophila</italic> cells.</title><p>(<bold>A</bold>) Schematic of the SAM complex for inducible transcriptional activation. dCas9-VP64 and MCP-p65-HSF1 were driven by an inducible metallothionein promoter. dCas9-VP64 and MCP-p65-HSF1 were expressed as T2A-containing bicistronic transcript. single-guide RNA (sgRNA) was expressed from pLib8 plasmid, which contains an <italic>attB</italic> flanking GFP-T2A-PuroR cassette for <italic>attP</italic> sites recombination. (<bold>B</bold>) Fold activation of <italic>Jon25Biii</italic> and <italic>Sdr</italic> expression measured by qPCR. Three biological replicates are shown as individual circles. (<bold>C</bold>) Fold activation of <italic>CG9877</italic> and <italic>CG13538</italic> expression measured by qPCR. Three biological replicates are shown as individual circles. <italic>t</italic>-test, *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ns, not significant.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig1-v1.tif"/></fig><p>The SAM complex modulates gene expression by recruiting transcriptional activators to gene promoters at endogenous genomic loci. In the <italic>Drosophila</italic> genome, 32% of genes form divergent gene pairs with transcriptional start sites (TSS) &lt;1 kb apart (<xref ref-type="bibr" rid="bib40">Yang and Yu, 2009</xref>). Thus, we next assessed the potential for collateral activation by the SAM complex of the closely spaced promoters. <italic>CG9877</italic> and <italic>CG13538</italic> are a divergent gene pair with transcriptional start sites 908 bp apart, thus this gene pair is a good test case for assessing collateral activation. sgRNAs were designed within a region 300 bp upstream of the TSS of <italic>CG9877</italic> and ~600 bp away from the TSS of <italic>CG13538</italic>. The sgRNAs specifically activated <italic>CG9877</italic>, but not <italic>CG13538</italic> (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), suggesting that the SAM complex activates the target gene without affecting nearby genes at least in some divergent gene pairs.</p></sec><sec id="s2-2"><title>Pooled CRISPRa screening with a focused library</title><p>Next, we used the SAM complex to perform a pooled CRISPRa screen. Unlike in mammalian cells, lentivirus vectors are extremely inefficient in <italic>Drosophila</italic> cells. To overcome this limitation, we previously established a pooled library delivery method based on site-specific recombination following plasmid transfection of <italic>Drosophila</italic> cells (<xref ref-type="bibr" rid="bib38">Viswanatha et al., 2018</xref>). In this method, <italic>attB</italic> sites flanking sgRNAs are integrated into <italic>attP</italic> sites flanking landing cassette in the presence of phiC31 integrase. We used the S2<italic>R</italic>+ PT5 cell line in which the <italic>attP</italic> cassette is inserted into the <italic>Clic</italic> locus (<xref ref-type="bibr" rid="bib23">Neumüller et al., 2012</xref>). To establish pooled library cells for CRISPRa screens, we first generated SAM cells that stably expressed the metallothionein promoter-driven SAM complex. Then, using phiC31-mediated cassette exchange, we integrated a pooled guide RNA library into the landing cassette (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><p>To test the pooled screen approach, we performed a CRISPRa screen to identify rapamycin resistance genes. Rapamycin is an allosteric inhibitor of the kinase mTOR, a key regulator of cell growth and proliferation. Rapamycin inhibits <italic>Drosophila</italic> S2<italic>R</italic>+ cell proliferation in a dose-dependent manner. Cell proliferation was partially inhibited by rapamycin at 0.1 nM and almost completely inhibited at 1 nM (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). To identify a suitable rapamycin treatment condition for a pooled CRISPRa screen, we performed a pilot-focused screen with different rapamycin concentrations and treatment durations. The focused library consists of 6335 sgRNAs targeting the promoter regions of 652 genes, which include genes involved in the mTOR signaling pathway as well as candidates from our previous CRISPR knockout screen (<xref ref-type="bibr" rid="bib38">Viswanatha et al., 2018</xref>). Pooled library cells were subjected to passaging in 0.1 nM, 1 nM rapamycin, or DMSO (vehicle) containing culture medium in parallel for 15 days or 30 days. After treatment, we examined sgRNA abundance in each condition by next-generation sequencing. First, we identified genes affecting cell fitness by comparing the final population after passaging in DMSO with the initial population. <italic>Scyl</italic> and <italic>Cyp12a4</italic> are significantly depleted (false-discovery rate (FDR)&lt;0.05) after passaging in DMSO for 15 days and 30 days (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>), suggesting that overexpression of <italic>scyl</italic> or <italic>Cyp12a4</italic> affects cell fitness. Consistent with this, <italic>scyl</italic> is known to inhibit cell proliferation and act as a cell death activator (<xref ref-type="bibr" rid="bib25">Reiling and Hafen, 2004</xref>; <xref ref-type="bibr" rid="bib7">Corradetti et al., 2005</xref>; <xref ref-type="bibr" rid="bib31">Scuderi et al., 2006</xref>). These results demonstrate that pooled CRISPRa screen can be used to identify genes affecting cell fitness.</p><p>We next identified rapamycin resistance genes by comparing the rapamycin-treated population with the DMSO-treated population, reasoning that sgRNAs that lead to activation of rapamycin resistance genes would be enriched after treatment due to a growth advantage in the presence of rapamycin. The focused screen revealed that one candidate, <italic>CG8468</italic>, was significantly enriched (FDR&lt;0.05) in the population treated with 1 nM rapamycin. Moreover, with prolonged treatment, <italic>CG8468</italic> was further enriched as we observed a higher fold-change value at day 30 than at day 15 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E and F</xref>). However, no gene was significantly enriched in the 0.1 nM rapamycin treatment condition, probably because cells have a higher proliferation rate at 0.1 nM rapamycin concentration compared to 1 nM. Taken together, these data demonstrate that pooled CRISPRa screen using the SAM complex is feasible in <italic>Drosophila</italic> cells.</p></sec><sec id="s2-3"><title>Genome-wide pooled CRISPRa screen</title><p>Next, we sought to screen for rapamycin resistance genes at the genome-wide scale. A previous study showed that multiplexed sgRNAs performed better than single sgRNAs for CRISPRi and CRISPRa (<xref ref-type="bibr" rid="bib26">Replogle et al., 2020</xref>). Thus, we designed a dual-sgRNA library in which each vector expressed two distinct sgRNAs targeting the promoter region of the same gene within 500 bp upstream of the TSS (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). The library consists of 84,143 vectors targeting the promoter regions of 13,293 protein-coding genes and 2332 non-coding genes. The dual-sgRNA library was constructed using a three-step pooled cloning strategy (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref> and Methods). After library construction, we checked the quality of the dual-sgRNA library by deep sequencing, which revealed that ~98.5% of designed vectors were present in the final library. The difference in representation between the 10<sup>th</sup> percentile of the final library (19 reads) and the 90<sup>th</sup> percentile (292 reads) was 15.5-fold (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). The integrity and distribution of our dual-sgRNA library are comparable to other published genome-wide libraries (<xref ref-type="bibr" rid="bib28">Sanjana et al., 2014</xref>), indicating the high quality of the library.</p><p>To establish the pooled library cells, we integrated the genome-wide dual-sgRNA library into SAM cells by phiC31-mediated cassette exchange. The pooled library cells were then passaged in 1 nM rapamycin or DMSO-containing medium for 3 weeks. The abundance of dual-sgRNA vectors in the initial and final cell populations following rapamycin or DMSO treatment was analyzed by next-generation sequencing (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). First, we identified genes affecting cell fitness by comparing the final population after passaging in DMSO for 3 weeks with the initial population. Consistent with the results of the focused screen, <italic>scyl</italic> is also significantly depleted (FDR&lt;0.05) in the genome-wide screen dataset. In addition to the <italic>scyl</italic>, the screen also identified other genes known to be involved in the suppression of cell proliferation (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref> and <xref ref-type="table" rid="table1">Table 1</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Genome-wide CRISPR activation screen for rapamycin resistance genes.</title><p>(<bold>A</bold>) Schematic of CRISPR activation screen (See methods). (<bold>B</bold>) Two replicates of genome-wide CRISPR activation screen. Data were analyzed by MAGeCK-RRA, a smaller RRA score indicates a stronger selection effect. Each circle represents a gene. Circle size corresponds to the significance (p value) of enrichment. Significantly enriched genes (false-discovery rate (FDR)&lt;0.05) are colored. (<bold>C</bold>) Fold activation of <italic>CG8468</italic> expression measured by qPCR. Three biological replicates are shown as individual circles. (<bold>D</bold>) Counts of sg<italic>CG8468</italic> vectors from the genome-wide screen. Each dot represents a vector. Vectors targeting intergenic regions are shown in blue. Vectors targeting <italic>CG8468</italic> are shown in red and annotated as V1-V6. (<bold>E</bold>) sg<italic>CG8468</italic>-expressing cell proliferation in cell mixture following 1 nM rapamycin or DMSO treatment. GFP proportion was measured by flow cytometry. Three biological replicates are shown as individual circles. (<bold>F</bold>) Fold activation of <italic>CG5399</italic> expression measured by qPCR. Three biological replicates are shown as individual circles. (<bold>G</bold>) Counts of sg<italic>CG5399</italic> vectors from the genome-wide screen. Each dot represents a vector. Vectors targeting intergenic regions are shown in blue. Vectors targeting <italic>CG5399</italic> are shown in red and annotated as V1-V6. (<bold>H</bold>) sg<italic>CG5399</italic>-expressing cell proliferation in cell mixture following 1 nM rapamycin or DMSO treatment. GFP proportion was measured by flow cytometry. Three biological replicates are shown as individual circles. (<bold>I</bold>) Fold activation of <italic>CG9932</italic> expression measured by qPCR. Three biological replicates are shown as individual circles. (<bold>J</bold>) Counts of sg<italic>CG9932</italic> vectors from the genome-wide screen. Each dot represents a vector. Vectors targeting intergenic regions are shown in blue. Vectors targeting <italic>CG9932</italic> are shown in red and annotated as V1-V6. (<bold>K</bold>) sg<italic>CG9932</italic>-expressing cell proliferation in cell mixture following 1 nM rapamycin or DMSO treatment. GFP proportion was measured by flow cytometry. Three biological replicates are shown as individual circles. <italic>t</italic>-test, *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ns, not significant.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Pooled CRISPR activation screen with a focused library.</title><p>(<bold>A</bold>) Schematic of pooled library cells generation. Synergistic activation mediator (SAM) complex was inserted into <italic>attP</italic> sites containing S2<italic>R</italic>+ cells to generate SAM cells. The pooled <italic>attB</italic> sites flanking single-guide RNA (sgRNA) library was integrated into <italic>attP</italic> sites by phiC31-mediated recombination to generate pooled library cells. (<bold>B</bold>) Cell proliferation of S2<italic>R</italic>+ cells with rapamycin treatment at different concentrations. Cell proliferation was measured by Cell titer Glo. Six replicates are shown as individual circles. (<bold>C</bold>) Pooled focused library screen with DMSO treatment for 15 days and 30 days. Data were analyzed by MAGeCK. Each dot represents a gene. Genes with significant differences (false-discovery rate (FDR)&lt;0.05) are highlighted. (<bold>D</bold>) Counts of sgRNAs targeting <italic>scyl</italic> or <italic>Cyp12a4</italic> in the initial population and final population after proliferation for 30 days in DMSO. Each dot represents a sgRNA. sgRNAs targeting <italic>scyl</italic> or <italic>Cyp12a4</italic> are highlighted. (<bold>E</bold>) Pooled-focused library screens with 0.1 nM and 1 nM rapamycin treatment for 15 days and 30 days. Data were analyzed by MAGeCK. Each dot represents a gene. Gene with a significant difference (FDR&lt;0.05) is highlighted. (<bold>F</bold>) Counts of sgRNAs targeting <italic>CG8468</italic> in the DMSO-treated population and rapamycin-treated population. Each dot represents a sgRNA. sgRNAs targeting <italic>CG8468</italic> are highlighted.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig2-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Design of genome-wide dual-sgRNA library.</title><p>(<bold>A</bold>) Schematic of dual-sgRNA library design. Two different sgRNAs targeting the same gene promoter region within 500 bp upstream of the transcriptional start site (TSS). Two sgRNAs were driven by separate U6 promoters. The <italic>attB</italic> sites flanking sgRNA sequence was integrated into <italic>attP</italic> sites flanking landing cassette by recombination-mediated cassette exchange (RMCE). (<bold>B</bold>) Schematic of genome-wide dual-sgRNA library construction by three-steps pooled cloning strategy. The oligo library containing Bbs1 and BsmB1 flanking sgRNA seed sequences was synthesized. The first library was constructed by inserting PCR products amplified from the oligo library. The second library was constructed by inserting the scaffold of the first sgRNA and the promoter of the second sgRNA using BsmB1 digestion and T4 ligation. The final library was constructed by inserting the sgRNA cassette into the destination vector using Bbs1 digestion and T4 ligation. (<bold>C</bold>) Histogram of sgRNA representation of the constructed dual-sgRNA library. Insert: Cumulative distribution of sgRNA sequencing reads. 10<sup>th</sup> and 90<sup>th</sup> percentiles are indicated by dash lines.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig2-figsupp2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Genome-wide cell fitness screen and rapamycin screen.</title><p>(<bold>A</bold>) Genome-wide cell fitness screen. Each dot represents a gene. Significantly depleted genes (false-discovery rate (FDR)&lt;0.05) after proliferation in DMSO for 3 weeks are highlighted. (<bold>B</bold>) Counts of sg<italic>CG8468</italic> vectors in genome-wide rapamycin screen. Each dot represents a vector. Vectors targeting the intergenic regions are shown in blue. Vectors targeting the candidates are shown in red and annotated as V1-V6. (<bold>C</bold>) Counts of sg<italic>CG5399</italic> vectors in genome-wide rapamycin screen. (<bold>D</bold>) Counts of sg<italic>CG9932</italic> vectors in genome-wide rapamycin screen.</p><p><supplementary-material id="fig2s3sdata1"><label>Figure 2—figure supplement 3—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig2-figsupp3-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig2-figsupp3-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Significantly depleted genes in genome-wide fitness screen.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Gene</th><th align="left" valign="bottom">Human ortholog</th><th align="left" valign="bottom">Known gene affecting cell fitness</th><th align="left" valign="bottom">Reference</th></tr></thead><tbody><tr><td align="left" valign="bottom">zld</td><td align="left" valign="bottom">ZNF485</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Eaat1</td><td align="left" valign="bottom">SLC1A3</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">CR44587</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Lis-1/Ptp52F<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">PAFAH1B1/Ptprb</td><td align="left" valign="bottom">LIS-1-overexpressing mitotic cells show a variety of spindle defects</td><td align="left" valign="bottom">PMID: 10722879</td></tr><tr><td align="left" valign="bottom">scyl</td><td align="left" valign="bottom">DDIT4</td><td align="left" valign="bottom">Scyl inhibits cell growth by regulating the Tor pathway</td><td align="left" valign="bottom">PMID: 15545626</td></tr><tr><td align="left" valign="bottom">αTub85E</td><td align="left" valign="bottom">TUBA1A</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Poxm</td><td align="left" valign="bottom">Pax9</td><td align="left" valign="bottom">PAX9 overexpression inhibits cancer cell proliferation</td><td align="left" valign="bottom">PMID: 35628401</td></tr><tr><td align="left" valign="bottom">Dll</td><td align="left" valign="bottom">DLX6</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">LKRSDH</td><td align="left" valign="bottom">AASS</td><td align="left" valign="bottom">Overexpression of Aass suppresses cancer cell proliferation</td><td align="left" valign="bottom">PMID: 31601242</td></tr><tr><td align="left" valign="bottom">scro</td><td align="left" valign="bottom">NKX2-1</td><td align="left" valign="bottom">NKX2-1 suppresses lung cancer progression by dampening ERK activity</td><td align="left" valign="bottom">PMID: 34689179</td></tr><tr><td align="left" valign="bottom">CG3168</td><td align="left" valign="bottom">SV2A</td><td align="left" valign="bottom">Overexpression of SV2A inhibits the PI3K signaling pathway</td><td align="left" valign="bottom">PMID: 34277597</td></tr><tr><td align="left" valign="bottom">CG2930</td><td align="left" valign="bottom">SLC15A1</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>Lis-1 and Ptp52F form divergent gene pair ~500 bp apart.</p></fn></table-wrap-foot></table-wrap><p>By comparing the rapamycin-treated population with the DMSO-treated population, we identified rapamycin resistance genes. <italic>Pka-C3</italic> and <italic>Cdc25</italic> were among the top 50 ranked genes identified in both replicates of the genome-wide screen (<xref ref-type="table" rid="table2">Table 2</xref>). <italic>Pka-C3</italic> encodes the catalytic subunit of PKA, and overexpression of the catalytic subunit of PKA or activation of the PKA pathway is known to confer resistance to rapamycin (<xref ref-type="bibr" rid="bib8">Cutler et al., 2001</xref>; <xref ref-type="bibr" rid="bib45">Zurita-Martinez and Cardenas, 2005</xref>; <xref ref-type="bibr" rid="bib30">Schmelzle et al., 2004</xref>). <italic>Cdc25</italic> is a tyrosine phosphatase gene that regulates cell cycle progression. Previous studies have indicated that the level of <italic>Cdc25</italic> expression is positively correlated with rapamycin resistance in cancer cells (<xref ref-type="bibr" rid="bib24">Reikvam et al., 2014</xref>; <xref ref-type="bibr" rid="bib6">Chen et al., 2009</xref>).</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Overlapping genes of top-ranked 50 hits from two genome-wide screen replicates.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Rank (Rep 1, Rep 2)</th><th align="left" valign="bottom">Gene</th><th align="left" valign="bottom">Human ortholog</th><th align="left" valign="bottom">Function</th><th align="left" valign="bottom">Known rapamycin resistance gene</th></tr></thead><tbody><tr><td align="left" valign="bottom">1, 1</td><td align="left" valign="bottom">CG8468</td><td align="left" valign="bottom">SLC16A8</td><td align="left" valign="bottom">monocarboxylate transporter</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">2, 3</td><td align="left" valign="bottom">CG5399</td><td align="left" valign="bottom">APOD/LCN2</td><td align="left" valign="bottom">lipocalin</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">5, 2</td><td align="left" valign="bottom">CG9932</td><td align="left" valign="bottom">ZFN462/REST</td><td align="left" valign="bottom">transcription factor</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">4, 10</td><td align="left" valign="bottom">CG34459</td><td align="char" char="." valign="bottom">/</td><td align="left" valign="bottom">unknown</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">22, 13</td><td align="left" valign="bottom">Pka-C3</td><td align="left" valign="bottom">PRKX</td><td align="left" valign="bottom">catalytic subunit of PKA</td><td align="left" valign="bottom">PMID: 15643061, 14673167, 11739804</td></tr><tr><td align="left" valign="bottom">41, 8</td><td align="left" valign="bottom">Ps</td><td align="left" valign="bottom">NOVA1</td><td align="left" valign="bottom">RNA splicing</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">43, 45</td><td align="left" valign="bottom">CDC25</td><td align="left" valign="bottom">CDC25A/CDC25B</td><td align="left" valign="bottom">tyrosine phosphatase</td><td align="left" valign="bottom">PMID: 24383842, 19276368</td></tr></tbody></table></table-wrap><p>In addition to the known rapamycin resistance genes, novel candidates were also identified in the CRISPRa screen. In particular, three genes, <italic>CG8468</italic>, <italic>CG5399,</italic> and <italic>CG9932</italic>, were significantly enriched (FDR&lt;0.05) in both replicates (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). <italic>CG8468</italic> is a member of the SLC16 family of monocarboxylate transporters. <italic>CG5399</italic> encodes a member of the lipocalin protein family, members of which have been implicated in lipid binding and transport. <italic>CG9932</italic> encodes a zinc finger C2H2 transcription factor. Interestingly, <italic>CG8468</italic> was also the top hit from our focused library screen, indicating the consistency of the pooled CRISPRa screen approach in <italic>Drosophila</italic> cells (note that the other two genes were not included in the focused library).</p></sec><sec id="s2-4"><title>Validation of the novel rapamycin resistance genes</title><p>To validate that the novel hits from the CRISPRa screen could indeed confer resistance to rapamycin, we first cloned all dual-sgRNA vectors targeting <italic>CG8468</italic>, <italic>CG5399,</italic> or <italic>CG9932</italic> that were present in the genome-wide library and established individual stable SAM cell lines for each vector. The target activation efficiency of each vector was evaluated in individual cell lines by qPCR. The dual-sgRNA vectors showed variable activation efficiency, probably due to the complex transcriptional regulation of the target genes or different sgRNA binding efficiencies (<xref ref-type="fig" rid="fig2">Figure 2C, F and I</xref>). Interestingly, the enrichment of each dual-sgRNA vector in the screen was highly correlated with its target activation efficiency, as only the vectors that efficiently activate target genes were enriched in the rapamycin-treated samples (<xref ref-type="fig" rid="fig2">Figure 2D, G and J</xref> and <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B–D</xref>). Collectively, these results confirm that the sgRNA vectors enriched in the screen were able to upregulate the target genes.</p><p>To validate that overexpression of the hits confers a growth advantage in the presence of rapamycin, we mixed wild-type SAM cells (GFP negative) and individual dual-sgRNA vector expressing cell lines (GFP positive), then monitored the proportion of GFP-positive cells in the mixed cell populations following 1 nM rapamycin or DMSO treatment for 2 weeks. We reasoned that if a dual-sgRNA vector confers resistance to rapamycin, cells with the vector will proliferate more than wild-type SAM cells in the presence of rapamycin, leading to a higher proportion of GFP-positive cells in the rapamycin-treated sample as compared to the DMSO-treated sample. As expected, we only observed higher proportions of GFP for vectors that efficiently activate target genes, but not for inefficient vectors or an empty vector (<xref ref-type="fig" rid="fig2">Figure 2E, H and K</xref>). These results confirmed that overexpression of the hits from the genome-wide screen conferred resistance to rapamycin.</p></sec><sec id="s2-5"><title>RTK-Akt-mTOR signaling activation by <italic>CG5399</italic> overexpression</title><p>To characterize the mechanism of rapamycin resistance, we first examined the mTOR activity in SAM cell lines with dual-sgRNA vectors activating the target genes. As ribosomal protein S6 is phosphorylated by S6K, which is a downstream target of mTOR, the phosphorylation status of S6 can serve as a readout for mTOR activity. In the presence of rapamycin, S6 phosphorylation was strongly inhibited in wild-type SAM cells and empty vector-expressing SAM cells. In contrast, compared to control cells, the phospho-S6 levels were dramatically elevated in <italic>CG5399</italic>-overexpressing cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Interestingly, we did not observe higher phospho-S6 levels in <italic>CG8468</italic>-overexpressing cells, suggesting that <italic>CG8468</italic> acts downstream of mTOR or in a parallel pathway. <italic>CG9932</italic>-overexpressing cells also displayed higher phospho-S6 levels, possibly reflecting a previous observation that overexpression of the human ortholog of <italic>CG9932</italic>, REST, activates Akt, which acts upstream of S6 (<xref ref-type="bibr" rid="bib10">Dobson et al., 2019</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>CG5399</italic> overexpression activates RTK-Akt-mTOR signaling.</title><p>(<bold>A</bold>) Phospho-S6 levels in cells expressing dual-sgRNA vectors in the presence of 1 nM rapamycin. Western blot signals are quantitatively analyzed by ImageJ. Three biological replicates are shown as individual circles. (<bold>B</bold>) Phospho-S6 levels in cells expressing sg<italic>CG5399</italic> vectors without rapamycin treatment. Western blot signals are quantitatively analyzed by ImageJ. Four biological replicates are shown as individual circles. (<bold>C</bold>) Phospho-Akt and Phospho-S6 in <italic>CG5399</italic>-overexpressing cells following <italic>CG5399</italic> knockdown. Two nonoverlapping double-stranded RNAs (dsRNAs) targeting <italic>CG5399</italic> were used. (<bold>D</bold>) Phospho-Akt and Phospho-S6 in <italic>CG5399</italic>-overexpressing cells following insulin receptor (<italic>InR)</italic> knockdown. Two nonoverlapping dsRNAs targeting <italic>InR</italic> were used. (<bold>E</bold>) Phospho-InR, phospho-Akt, and phospho-S6 in sg<italic>CG5399</italic>-expressing synergistic activation mediator (SAM) cells. (<bold>F</bold>) Phospho-InR, phospho-Akt, and phospho-S6 in <italic>CG5399</italic> ORF-overexpressing S2<italic>R</italic>+ cells using UAS-Gal4. <italic>t</italic>-test, **&lt;0.01; ***p&lt;0.001; ns, not significant.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig3-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>CG5399</italic> overexpression activates Akt-mTOR through RTK/PI3K.</title><p>(<bold>A</bold>) Phospho-Akt in <italic>CG5399</italic>-overexpressing cells following <italic>Pi3K92E</italic> knockdown. Two nonoverlapping double-stranded RNAs (dsRNAs) targeting <italic>Pi3K92E</italic> were used. (<bold>B</bold>) Phospho-Akt and phospho-S6 in <italic>CG5399</italic>-overexpressing cells following PDGF/VEGF receptor (<italic>Pvr)</italic> knockdown. Two nonoverlapping dsRNAs targeting <italic>Pvr</italic> were used. (<bold>C</bold>) Phospho-InR and phospho-Akt in <italic>CG5399</italic>-overexpressing cells following serum starvation for 2 hr.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig3-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig3-figsupp1-v1.tif"/></fig></fig-group><p>The increase of phospho-S6 levels in <italic>CG5399</italic>-overexpressing cells in the presence of rapamycin might be explained by different mechanisms: (1) <italic>CG5399</italic> might alter the pharmacokinetics of rapamycin, decreasing cellular rapamycin concentrations; (2) <italic>CG5399</italic> might competitively bind to rapamycin, releasing mTOR from inhibition; (3) <italic>CG5399</italic> might be a positive regulator of mTOR signaling. To distinguish among these possibilities, phospho-S6 was assessed in <italic>CG5399</italic>-overexpressing cells without rapamycin treatment. Compared with wild-type SAM cells and empty vector-expressing SAM cells, higher phospho-S6 levels were observed in <italic>CG5399</italic>-overexpressing cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), indicating that <italic>CG5399</italic> is a positive regulator of mTOR. Moreover, in addition to higher phopho-S6 levels, an increase in phospho-Akt was also observed in <italic>CG5399</italic>-overexpressing cells. Furthermore, knocking down <italic>CG5399</italic> mRNA levels using either of two nonoverlapping double-stranded RNAs (dsRNAs) in <italic>CG5399</italic>-overexpressing cells totally abolished the increase of phospho-Akt and phospho-S6 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), excluding the possibility that an off-target effect of the sgRNAs explains these observations.</p><p>Akt is phosphorylated by PI3K when receptor tyrosine kinases (RTKs) are activated. To test whether PI3K is involved in Akt activation by <italic>CG5399</italic> overexpression, we used two nonoverlapping dsRNAs to deplete the catalytic subunit of PI3K, <italic>Pi3K92E</italic>, in <italic>CG5399</italic>-overexpressing cells. Knockdown of <italic>Pi3K92E</italic> abolished Akt activation by <italic>CG5399</italic> overexpression, suggesting that <italic>CG5399</italic> activates Akt-mTOR through PI3K (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). As Akt is regulated by both insulin receptor (InR) and PDGF/VEGF receptor (Pvr) (<xref ref-type="bibr" rid="bib34">Sopko et al., 2015</xref>), we examined whether <italic>InR</italic> and <italic>Pvr</italic> are involved in <italic>CG5399</italic> function. Two nonoverlapping dsRNAs targeting <italic>InR</italic> or <italic>Pvr</italic> were transfected into <italic>CG5399</italic>-overexpressing cells. Knockdown of <italic>InR</italic> or <italic>Pvr</italic> inhibited upregulation of phospho-Akt and phospho-S6 induced by <italic>CG5399</italic> overexpression (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>), suggesting that <italic>CG5399</italic> activates Akt-mTOR via <italic>InR</italic> and <italic>Pvr</italic>. As expected, higher phospho-InR levels were also observed in <italic>CG5399</italic>-overexpressing cells (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) in a normal medium without insulin stimulation. Finally, the activation of InR-Akt-mTOR signaling in S2<italic>R</italic>+ cells was also observed with <italic>CG5399</italic> ORF overexpression by co-transfecting <italic>pUAS-CG5399</italic> and <italic>pActin-Gal4</italic> vectors (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), further excluding the possibility that off-targets of sgRNAs contribute to the phenotype. Taken together, these data demonstrate that <italic>CG5399</italic> overexpression activates RTK-Akt-mTOR signaling in a normal medium without insulin stimulation.</p><p>Insulin receptors form covalent homodimers at the cell surface. Upon insulin binding, the ectodomain of InR changes from the inverted U-shape structure to the T-shape structure, facilitating the proximity and autophosphorylation of the cytoplasmic kinase domains (<xref ref-type="bibr" rid="bib13">Gutmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Scapin et al., 2018</xref>). <italic>Drosophila</italic> cells are cultured in Schneider medium supplemented with 10% FBS (fetal bovine serum). The Schneider medium only consists of amino acids and inorganic salts while FBS is a biological product that might contain a trace amount of insulin and insulin-like growth factors (<xref ref-type="bibr" rid="bib37">Tu et al., 2018</xref>). As we observed that <italic>CG5399</italic> overexpression activates the InR in a normal medium without insulin stimulation, we removed FBS from the culture medium to further exclude the effect of insulin and insulin-like growth factors in FBS. Increase of phospho-InR and phospho-Akt in <italic>CG5399</italic>-overexpressing cells could still be observed after serum starvation for 2 hr (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), suggesting InR activation by <italic>CG5399</italic> overexpression does not require insulin.</p></sec><sec id="s2-6"><title>InR regulation by <italic>CG5399</italic> requires cholesterol and clathrin-coated pits</title><p>InR is embedded in the lipid bilayer environment of the cell membrane. Given that <italic>CG5399</italic> encodes a member of the lipocalin protein family, members of which have been implicated in the binding and transport of lipid molecules, we hypothesized that <italic>CG5399</italic> might regulate InR by remodeling lipid components at the cell membrane. Structure prediction of CG5399 by AlphaFold revealed a highly conserved barrel structure formed by eight beta-sheets as a putative ligand pocket (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), similar to the crystal structures of lipocalins in other species (<xref ref-type="bibr" rid="bib4">Breustedt et al., 2005</xref>; <xref ref-type="bibr" rid="bib18">Lakshmi et al., 2015</xref>). Molecular docking simulation indicated that cholesterol can be inserted into the barrel structure of CG5399 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), suggesting that cholesterol might be a substrate of CG5399.</p><p>To test whether cholesterol is relevant to <italic>CG5399</italic> function, we used methyl-beta-cyclodextrin (MβCD) to deplete cholesterol from cell membranes in <italic>CG5399</italic>-overexpressing cells. MβCD is a heptasaccharide with a high affinity to cholesterol and has been widely used to manipulate membrane cholesterol content (<xref ref-type="bibr" rid="bib44">Zidovetzki and Levitan, 2007</xref>). MβCD treatment eliminated the increase of phospho-InR, phospho-Akt, and phospho-S6 in a dose-dependent manner in <italic>CG5399</italic>-overexpressing cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), indicating that activation of InR-Akt-mTOR by <italic>CG5399</italic> overexpression requires cholesterol at the membrane. Moreover, supplementation of cholesterol into the cell membrane can rescue the decrease of phospho-Akt induced by MβCD treatment in <italic>CG5399</italic>-overexpressing cells, excluding the possibility that an off-target effect of MβCD contributes to the observed effect (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). To test the possibility that MβCD treatment affected the normal function of InR, S2<italic>R</italic>+ cells were stimulated with insulin following MβCD treatment. No difference in insulin response was observed in MβCD treated and untreated cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>), suggesting that MβCD treatment does not affect InR function. Moreover, direct supplementation of cholesterol to the cell membrane activated InR-Akt-mTOR signaling in wild-type S2<italic>R</italic>+ cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), indicating that an increase in the level of cholesterol at the cell membrane was able to activate InR.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Activation of InR-Akt-mTOR signaling by <italic>CG5399</italic> overexpression requires cholesterol and clathrin-coated pits at the membrane.</title><p>(<bold>A</bold>) Phospho-InR, phospho-Akt, and phospho-S6 in <italic>CG5399</italic>-overexpressing cells treated with methyl-beta-cyclodextrin (MβCD) at different concentrations. (<bold>B</bold>) Phospho-InR, phospho-Akt, and phospho-S6 in S2<italic>R</italic>+ cells with cholesterol supplementation. Two different cholesterol products from Sigma (C3045 for Lane 3 and C2044 for Lane 4) were used. (<bold>C</bold>) Phospho-Akt in <italic>CG5399</italic>-overexpressing cells following <italic>Flo1</italic>, <italic>Flo2,</italic> or <italic>Chc</italic> knockdown. Two nonoverlapping double-stranded RNAs (dsRNAs) targeting each gene were used. (<bold>D</bold>) Phospho-InR in <italic>CG5399</italic>-overexpressing cells following <italic>Chc</italic> knockdown. Two nonoverlapping dsRNAs targeting each gene were used. (<bold>E</bold>) Phospho-InR in S2<italic>R</italic>+ cells with cholesterol supplementation following clathrin heavy chain (<italic>Chc)</italic> knockdown. Two nonoverlapping dsRNAs targeting each gene were used.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig4-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>CG5399</italic> interacts with cholesterol by molecular docking.</title><p>(<bold>A</bold>) Structure prediction of <italic>CG5399</italic> by AlphaFold. Different side views are shown. (<bold>B</bold>) Interaction between <italic>CG5399</italic> and cholesterol by molecular docking. Cholesterol is predicted to be inserted into the barrel structure of <italic>CG5399</italic> in two different configurations. (<bold>C</bold>) Phospho-Akt in <italic>CG5399</italic>-overexpressing cells supplemented with cholesterol following methyl-beta-cyclodextrin (MβCD) treatment. (<bold>D</bold>) Phospho-InR, phospho-Akt in S2<italic>R</italic>+ cells stimulated with insulin following MβCD treatment. Different insulin concentrations and treatment durations were tested. (<bold>E</bold>) Schematic model of InR-Akt-mTOR activation in CG5399 overexpressing cells.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Full source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85542-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Cell membranes form distinct microdomains, such as caveolin-coated caveolae, flotillin-coated microdomains, and clathrin-coated pits. Cholesterol is required for the formation of different microdomains (<xref ref-type="bibr" rid="bib20">Lu and Fairn, 2018</xref>). To distinguish which microdomain was involved in the <italic>CG5399</italic> function, we knocked down flotillins and clathrins in <italic>CG5399</italic>-overexpressing cells using dsRNAs. Knockdown of flotillin genes (<italic>Flo1</italic> and <italic>Flo2</italic>) did not affect phospho-Akt, whereas the increase of phospho-InR and phospho-Akt normally observed in <italic>CG5399</italic>-overexpression cells was dampened by knockdown of clathrin heavy chain (<italic>Chc</italic>) (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). Moreover, InR activation by cholesterol supplementation was also eliminated by <italic>Chc</italic> knockdown (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Taken together, these results suggest that InR-Akt-mTOR signaling activation by <italic>CG5399</italic> overexpression requires cholesterol and clathrin-coated pits at the cell membrane.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Although genome-wide LOF screens in <italic>Drosophila</italic> cells have helped elucidate the mechanism of a variety of biological processes, genome-wide GOF screens have not been feasible in this organism. To address this gap, we generated a genome-wide dual-sgRNA library that covers both protein-coding genes and non-coding genes. This library also captures transcriptional complexity by targeting alternative promoters of the same gene, making it suitable for screens in different contexts in the future. Moreover, in this library, each gene is targeted by 4–6 dual-sgRNA vectors, which helps overcome the inefficient activation by some sgRNAs to some extent. Indeed, we observed that some dual-sgRNA vectors failed to activate the target genes (<xref ref-type="fig" rid="fig2">Figure 2F and I</xref>), possibly due to steric hindrance by pre-existing proteins in the promoter regions, or due to different sgRNA binding efficiency, which might be optimized by applying machine learning to large screen datasets in the future. In our method, the synthetic transcriptional activators of the SAM complex (dCas9-VP64 and MCP-p65-HSF1) are driven by the metallothionein promoter. Due to the leaky expression of this promoter, we observed moderate gene activation without copper induction. Availability of a tighter controlled promoter may be required for more sensitive screens. As the <italic>Drosophila</italic> genome is relatively compact, one concern for CRISPRa is the collateral activation of adjacent genes. Previous work has shown that sgRNAs targeting areas beyond –600 bp from the TSS in <italic>Drosophila</italic> lose efficiency (<xref ref-type="bibr" rid="bib21">Mao et al., 2020</xref>), which may alleviate the concern of collateral activation when the sgRNAs target sites are over 600 bp away from the TSS of neighboring genes. In some cases, sgRNAs are designed within both promoters of closely spaced divergent genes. If the hits from the screen form closely spaced divergent gene pairs, e.g., <italic>Lis-1</italic> and <italic>Ptp52F</italic> in the cell fitness screen (<xref ref-type="table" rid="table1">Table 1</xref>), more experiments will be required to identify which one contributes to the phenotype. Currently, in our CRISPRa system, spCas9 requires NGG as a protospacer-adjacent motif (PAM) sequence, which limits sgRNA design in the small region upstream of TSS, especially for closely spaced genes. Next-generation CRISPRa system could use PAMless Cas9 variants (<xref ref-type="bibr" rid="bib39">Walton et al., 2020</xref>) to remove the PAM constraint for sgRNA design, allowing the construction of libraries with more sgRNAs per gene.</p><p>Our genome-wide genetic screen identified some known rapamycin resistance genes and novel candidates. Overexpression of <italic>CG5399</italic>, which encodes a lipocalin family protein, confers resistance to rapamycin and activates RTK-Akt-mTOR signaling. The activation of InR by <italic>CG5399</italic> requires cholesterol and clathrin-coated pits at the cell membrane (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). CG5399 is predicted to have a transmembrane helix at the C-terminus by PredictProtein and be located on the cell membrane by DeepLoc. As InR is embedded in the cell membrane and the rearrangement of InR transmembrane domain is crucial for tyrosine kinase domain activation, changing the lipid environment is a reasonable possible mechanism for the regulation of InR activation (<xref ref-type="bibr" rid="bib13">Gutmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Scapin et al., 2018</xref>). A recent study showed that lipid exchange to form ordered domains at cell membranes induces InR autophosphorylation (<xref ref-type="bibr" rid="bib36">Suresh et al., 2021</xref>). In our experiment, we observed higher InR activity in <italic>CG5399</italic>-overexpressing cells without insulin stimulation, suggesting that InR activation can be regulated by the lipid environment. The clinical relevance of this InR activation mechanism needs to be further investigated.</p><p>In conclusion, we have established a genome-wide CRISPRa platform in <italic>Drosophila</italic> cells and identified novel rapamycin resistance genes using a genome-wide CRISPRa screen platform. This platform can be applied broadly to help elucidate the cellular mechanisms of a variety of biological processes.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">CG8468</td><td align="left" valign="bottom">FlyBase</td><td align="left" valign="bottom">FLYB:FBgn0033913</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">CG5399</td><td align="left" valign="bottom">FlyBase</td><td align="left" valign="bottom">FLYB:FBgn0038353</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">CG9932</td><td align="left" valign="bottom">FlyBase</td><td align="left" valign="bottom">FLYB:FBgn0262160</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">S2R+</td><td align="left" valign="bottom">DRSC</td><td align="left" valign="bottom">FLYB:FBtc0000150</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">PT5</td><td align="left" valign="bottom">DRSC</td><td align="left" valign="bottom">FLYB:FBtc0000229</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">E.cloni10GF’ Electrocompetent Cells</td><td align="left" valign="bottom">Biosearch Technologies</td><td align="left" valign="bottom">60061–2</td><td align="left" valign="bottom">sgRNA library construction</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">One Shot TOP10 Chemically Competent <italic>E. coli</italic></td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">C404010</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Recombinant Anti-Insulin Receptor (phospho Y1185) antibody (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab62321</td><td align="char" char="." valign="bottom">1:1000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Phospho-Akt (Ser473) (D9E) XP antibody (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">4060</td><td align="char" char="." valign="bottom">1:1000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Akt Rabbit Antibody (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">9272</td><td align="char" char="." valign="bottom">1:1000 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">StarBright Blue 700 Goat Anti-Rabbit IgG</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">12004161</td><td align="char" char="." valign="bottom">1:2500 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">StarBright Blue 520 Goat Anti-Rabbit IgG</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">12005869</td><td align="char" char="." valign="bottom">1:2500 for WB</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">hFAB Rhodamine Anti-Actin Primary Antibody (synthesized, monoclonal)</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">12004163</td><td align="char" char="." valign="bottom">1:2500 for WB</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMK33-SAM plasmid</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Can be obtained from DRSC</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLib8 plasmid</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">U6:3-MS2 sgRNA cassette, can be obtained from DRSC</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pBS130 plasmid</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">26290</td><td align="left" valign="bottom">PhiC31 integrase</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUAS-CG5399 plasmid</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">CG5399 ORF vector, cassette, can be obtained from DRSC</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Effectene Transfection Reagent</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">301425</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">CellTiter-Glo Luminescent Cell Viability Assay</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">G7570</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy Mini Kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">74104</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">iScript cDNA Synthesis Kit</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">1708890</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MEGAscript T7 Transcription Kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">AM1334</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Methyl-β-cyclodextrin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C4555</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cholesterol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C3045</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cholesterol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C2044</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 7</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Vectors</title><p>The pMK33-SAM plasmid was generated by transferring the SAM sequence from the flySAM vector (<xref ref-type="bibr" rid="bib15">Jia et al., 2018</xref>) into the pMK33 plasmid. MS2 hairpin containing sgRNA was expressed from the pLib8 plasmid. pLib8 is derived from pLib6.4 (<xref ref-type="bibr" rid="bib38">Viswanatha et al., 2018</xref>) by replacing the U6:2-sgRNA cassette to the U6:3-MS2 sgRNA cassette. The PhiC31 integrase expressing pBS130 plasmid was obtained from Addgene (#26290). The full length of <italic>CG5399</italic> was cloned from the cDNA of S2<italic>R</italic>+ cells and inserted into the pWalium10 vector (DGRC, 1470) to construct the <italic>pUAS-CG5399</italic> vector. sgRNA sequences used in this study are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-2"><title>Antibodies</title><p>Phospho-InR antibody (Abcam, #ab62321), Phospho-Akt antibody (Cell signaling, # 4060), Akt antibody (Cell signaling, #9272) were used in this study. Phospho-S6 antibody is a kind gift of <xref ref-type="bibr" rid="bib16">Kim and Choi, 2019</xref>.</p></sec><sec id="s4-3"><title>Cell culture, transfection, and proliferation assay</title><p><italic>Drosophila</italic> cells were cultured with Schneider medium (Gibco) supplemented with 10% heat-inactivated FBS (Gibco) at 25°C (<xref ref-type="bibr" rid="bib38">Viswanatha et al., 2018</xref>) unless otherwise indicated. The wild-type S2<italic>R</italic>+ cell line and the <italic>attP</italic> sites containing S2<italic>R</italic>+ derivative PT5 cell line were obtained from the <italic>Drosophila</italic> RNAi Screening Center. The DRSC copy of S2<italic>R</italic>+ was authenticated by the <italic>Drosophila</italic> Genomics Resource Center (DGRC), as part of their development of a transposable element-based authentication protocol for <italic>Drosophila</italic> cell lines (<xref ref-type="bibr" rid="bib22">Mariyappa et al., 2022</xref>). The presence of the recombination cassette was confirmed by observation of mCherry fluorescence and the successful introduction of sgRNAs via recombination-mediated cassette exchange. Mycoplasma contamination is not an issue for <italic>Drosophila</italic> cell lines; throughout the study, we monitored and confirmed through careful observation that media and cells were not infected by bacteria or fungi. The cell lines used in this study are not from the list of commonly misidentified cell lines maintained by the International Cell Line Authentication Committee. PT5 cells were transfected with pMK33-SAM plasmid using Effectene (QIAGEN) according to the manufacturer’s protocol. Briefly, 3 × 10<sup>6</sup> <italic>Drosophila</italic> cells were seeded into one well of a six-well plate before transfection. 400 ng plasmids were diluted into Buffer EC to a final volume of 100 μL and mixed with 3.2 μL enhancer by vortexing to form a DNA-enhancer mixture. 10 μL Effectene transfection reagents were added into the DNA-enhancer mixture and mixed by vortexing. After incubating at room temperature for 15 min to allow transfection complex formation, the solution was added drop-wise onto <italic>Drosophila</italic> cells. Transfected cells were passaged in a culture medium containing 200 μg/mL Hygromycin B (Millipore) for 1 month to generate the stable SAM cell line. To induce SAM complex expression, a culture medium containing 100 μM CuSO<sub>4</sub> (Sigma) was used. Cell proliferation under different rapamycin concentrations was tested using CellTiter Glo assay (Promega) according to the manufacturer’s protocol. 1 × 10<sup>4</sup> <italic>Drosophila</italic> cells were seeded into each well of a 96-well plate. Rapamycin-containing culture medium was added into each well to make the final concentration from 10<sup>–4</sup> nM to 10 nM. After culturing for 4 days, a volume of CellTiter Glo reagent was added into each well before cells reached confluence. The luminescence signal was measured by Plate Reader (Molecular Devices).</p></sec><sec id="s4-4"><title>Pooled library design and construction</title><p>For the focused sgRNA library, sgRNAs were designed within 500 bp upstream of the transcriptional start site (TSS) for each gene. Ten different sgRNAs were selected for each gene unless fewer sgRNA binding sites were found within the window. Constructing the focused library was performed as previously described (<xref ref-type="bibr" rid="bib38">Viswanatha et al., 2018</xref>). Briefly, Bbs1 sites flanking sgRNA spacer sequences were synthesized as single-stranded DNA oligos (Agilent). DNA oligos were amplified by PCR using Phusion Polymerase (New England Biolabs). Bbs1 restriction enzyme (New England Biolabs) was used to digest amplicon and pLib8 plasmid. The resulting 24-mer fragment was purified from the Bbs1 digested amplicon by running a 20% TBE polyacrylamide gel (Thermo). The purified fragment and plasmid were ligated using T4 ligase (New England Biolabs). The ligation products were transferred into Ecloni 10GF’ electrocompetent cells (Lucigen) using Gene Pulser Xcell Electroporation Systems (Bio-Rad). Transformed bacteria were spread on LB-carbenicillin agar plates. After overnight culture, the bacteria colonies were collected from plates by scraping and amplified in an LB medium with ampicillin.</p><p>For the genome-wide dual-sgRNA library, sgRNAs were designed within 500 bp upstream of TSS for each gene. sgRNAs were chosen to make six dual-sgRNA combinations for each gene unless fewer sgRNA binding sites were found. To construct the dual-sgRNA library, Bbs1, and BsmB1 sites flanking two sgRNA spacer sequences were synthesized in a custom array as single-stranded DNA oligos (Agilent). DNA oligos were amplified by PCR using Phusion Polymerase (New England Biolabs). DNA amplicons were ligated to Zero Blunt vector (Thermo) using T4 ligase to generate the first library. An amplicon containing the scaffold sequence for the first sgRNA and U6:2 promoter sequence for the second sgRNA was inserted into the BsmB1 site to generate the second library. The second library and pLib8 vector were digested with Bbs1. The resulting sgRNA cassettes from the digested second library were ligated with Bbs1 digested pLib8 vector to generate the final library using T4 ligase. Each library was transferred into Ecloni 10GF’ electrocompetent cells by electroporation. Transformed bacteria were spread on LB-carbenicillin agar plates. Bacteria colonies were calculated by serial dilution. Each library needs to reach at least 10 times diversity to maintain the integrity of the library.</p></sec><sec id="s4-5"><title>Pooled screening, library sequencing, and data analysis</title><p>The library was co-transfected with the same amount of phiC31 plasmid into SAM cells at 3 × 10<sup>6</sup> cells/well of a six-well plate using Effectene. The total cell number used for transfection was calculated to ensure over 1000 cells/sgRNA to maintain the integrity of the library. The transfected cells were passaged in a culture medium containing 5 μg/mL puromycin for 3 weeks to select the sgRNA-integrated cells. The resulting pooled library cells were split into two populations and passaged in rapamycin or DMSO-containing medium supplemented with 100 μM CuSO<sub>4</sub> for indicated days. After treatment, the genomic DNA was extracted from the final cell population and the sgRNAs sequences were amplified by PCR. As each <italic>Drosophila</italic> cell contains ~0.6 pg DNA, the amount of genomic DNA used as a PCR template was calculated to ensure over 1000 cells/sgRNA to maintain the diversity. The library for next-generation sequencing was constructed by adding Illumina adaptors to sgRNA amplicons by PCR. The final PCR products had the following sequence: P5-read1-(N)<sub>n</sub>-(B)<sub>6</sub>-sgRNA-P7 (where N stands for any nucleotide, n stands for a variable length of nucleotide from 1 to 10, and (B)<sub>6</sub> stands for six nucleotides sample barcode). PCR primers used for NGS library construction are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The library was sequenced using the NextSeq500 1 × 75 SE platform (Illumina) in HMS Biopolymers Facility. The sequencing data were de-multiplexed using TagDust. Screen hits were identified using MAGeCK-RRA by comparing the treatment and the control according to the previous report (<xref ref-type="bibr" rid="bib19">Li et al., 2014</xref>).</p></sec><sec id="s4-6"><title>RNA extraction, reverse transcription, and qPCR</title><p>RNA was extracted from <italic>Drosophila</italic> cells using RNA Mini Kit (QIAGEN) according to the manufacturer’s protocol. Total RNA was reverse transcribed into cDNA using the iScript cDNA Synthesis Kit (Bio-Rad). qPCR was done with SYBR Green Master Mix (Bio-Rad). The housekeeping gene <italic>rp49</italic> was used as the reference gene for qPCR. qPCR primers used in this study are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The statistical analysis was performed using the GraphPad Prism 7 software. <italic>t</italic>-tests were performed to test the significance of gene expression data. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ns, not significant.</p></sec><sec id="s4-7"><title>GFP proportion analysis by flow cytometry</title><p>Cells were transferred into 5 mL FACS tubes (Falcon 352235) and analyzed with a BD LSR II Flow Cytometer in the Department of Immunology Flow Cytometry Facility, Harvard Medical School. Wild-type cells (GFP negative cells) and an empty vector expressing cells (GFP positive cells) were used as a negative and positive control to set the gate in Alexa Fluor 488 channel, respectively. With this gate, the GFP proportion in wild-type cells is 0.031%, and in an empty vector expressing cells is 96.7%. Three biological replicates for each condition were tested. The flow cytometry files were analyzed by FlowJo. The statistical analysis was performed using the GraphPad Prism 7 software. <italic>t</italic>-tests were performed to test the significance of GFP proportion data. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ns, not significant.</p></sec><sec id="s4-8"><title>dsRNA synthesis and transfection</title><p>dsRNAs were designed by the <italic>Drosophila</italic> RNAi Screening Center. dsRNA templates were amplified from genomic DNA using primers with T7 promoter sequence <named-content content-type="sequence">TAATACGACTCACTATAGGG</named-content> at 5' end. dsRNAs were synthesized from the resulting amplicons using MEGAscript T7 Transcription Kit (Invitrogen). dsRNAs were purified with RNeasy Mini Kit (QIAGEN) before transfection. dsRNA sequences used in this study are listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. 10 μg dsRNA were transfected into 3 × 10<sup>6</sup> <italic>Drosophila</italic> cells using Effectene (QIAGEN).</p></sec><sec id="s4-9"><title>Cholesterol depletion and supplementation</title><p>For cholesterol depletion, methyl-beta-cyclodextrin (sigma) was dissolved in serum-free Schneider medium at the indicated concentration. Cells were incubated with MβCD containing serum-free medium for 1 hr before testing. For cholesterol supplementation, cholesterol (sigma) was dissolved in ethanol. Dissolved cholesterol was added into MβCD containing serum-free Schneider medium to form cholesterol/MβCD complex. Cells were incubated with cholesterol/MβCD complex containing serum-free Schneider medium for 1 hr before testing.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Writing - original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Formal analysis</p></fn><fn fn-type="con" id="con3"><p>Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Funding acquisition, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>sgRNA vectors used in this study.</title></caption><media xlink:href="elife-85542-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>PCR primers used in this study.</title></caption><media xlink:href="elife-85542-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>dsRNAs used in this study.</title></caption><media xlink:href="elife-85542-supp3-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-85542-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>The original files of the full raw unedited blots and figures with the uncropped blots with relevant bands labeled in this study.</title></caption><media xlink:href="elife-85542-data1-v1.zip" mimetype="application" mime-subtype="zip"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and source data files. The pMK33-SAM vector, pLib8 vector, and libraries used in this study are available through DRSC/TRiP Functional Genomics Resources.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>B</given-names></name><name><surname>Viswanatha</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Data from: Pooled genome-wide CRISPR activation screening for rapamycin resistance genes in <italic>Drosophila</italic> cells</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.2547d7ww8</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Jianquan Ni for the flySAM vector and Dr. Ah-Ram Kim for the phospho-S6 antibody. This work is supported by NIH NIGMS P41 GM132087 (NP) and NIH P01CA120964. NP is an investigator at Howard Hughes Medical Institute.</p><p>This article is subject to HHMI’s Open Access to Publications policy. HHMI lab heads have previously granted a nonexclusive CC BY 4.0 license to the public and a sublicensable license to HHMI in their research articles. Pursuant to those licenses, the author-accepted manuscript of this article can be made freely available under a CC BY 4.0 license immediately upon publication.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bard</surname><given-names>F</given-names></name><name><surname>Casano</surname><given-names>L</given-names></name><name><surname>Mallabiabarrena</surname><given-names>A</given-names></name><name><surname>Wallace</surname><given-names>E</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Kitayama</surname><given-names>H</given-names></name><name><surname>Guizzunti</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wendler</surname><given-names>F</given-names></name><name><surname>Dasgupta</surname><given-names>R</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Malhotra</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Functional genomics reveals genes involved in protein secretion and golgi organization</article-title><source>Nature</source><volume>439</volume><fpage>604</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1038/nature04377</pub-id><pub-id pub-id-type="pmid">16452979</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björklund</surname><given-names>M</given-names></name><name><surname>Taipale</surname><given-names>M</given-names></name><name><surname>Varjosalo</surname><given-names>M</given-names></name><name><surname>Saharinen</surname><given-names>J</given-names></name><name><surname>Lahdenperä</surname><given-names>J</given-names></name><name><surname>Taipale</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification of pathways regulating cell size and cell-cycle progression by rnai</article-title><source>Nature</source><volume>439</volume><fpage>1009</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1038/nature04469</pub-id><pub-id pub-id-type="pmid">16496002</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutros</surname><given-names>M</given-names></name><name><surname>Kiger</surname><given-names>AA</given-names></name><name><surname>Armknecht</surname><given-names>S</given-names></name><name><surname>Kerr</surname><given-names>K</given-names></name><name><surname>Hild</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>B</given-names></name><name><surname>Haas</surname><given-names>SA</given-names></name><name><surname>Paro</surname><given-names>R</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><collab>Heidelberg Fly Array Consortium</collab></person-group><year iso-8601-date="2004">2004</year><article-title>Genome-wide rnai analysis of growth and viability in <italic>Drosophila</italic> cells</article-title><source>Science</source><volume>303</volume><fpage>832</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1126/science.1091266</pub-id><pub-id pub-id-type="pmid">14764878</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breustedt</surname><given-names>DA</given-names></name><name><surname>Korndörfer</surname><given-names>IP</given-names></name><name><surname>Redl</surname><given-names>B</given-names></name><name><surname>Skerra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The 1.8-A crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>484</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1074/jbc.M410466200</pub-id><pub-id pub-id-type="pmid">15489503</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavez</surname><given-names>A</given-names></name><name><surname>Tuttle</surname><given-names>M</given-names></name><name><surname>Pruitt</surname><given-names>BW</given-names></name><name><surname>Ewen-Campen</surname><given-names>B</given-names></name><name><surname>Chari</surname><given-names>R</given-names></name><name><surname>Ter-Ovanesyan</surname><given-names>D</given-names></name><name><surname>Haque</surname><given-names>SJ</given-names></name><name><surname>Cecchi</surname><given-names>RJ</given-names></name><name><surname>Kowal</surname><given-names>EJK</given-names></name><name><surname>Buchthal</surname><given-names>J</given-names></name><name><surname>Housden</surname><given-names>BE</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>JJ</given-names></name><name><surname>Church</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comparison of cas9 activators in multiple species</article-title><source>Nature Methods</source><volume>13</volume><fpage>563</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3871</pub-id><pub-id pub-id-type="pmid">27214048</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>RQ</given-names></name><name><surname>Yang</surname><given-names>QK</given-names></name><name><surname>Lu</surname><given-names>BW</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Cantin</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>Fearns</surname><given-names>C</given-names></name><name><surname>Yates</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cdc25B mediates rapamycin-induced oncogenic responses in cancer cells</article-title><source>Cancer Research</source><volume>69</volume><fpage>2663</fpage><lpage>2668</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-3222</pub-id><pub-id pub-id-type="pmid">19276368</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corradetti</surname><given-names>MN</given-names></name><name><surname>Inoki</surname><given-names>K</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>9769</fpage><lpage>9772</lpage><pub-id pub-id-type="doi">10.1074/jbc.C400557200</pub-id><pub-id pub-id-type="pmid">15632201</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>NS</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Heitman</surname><given-names>J</given-names></name><name><surname>Cardenas</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The TOR signal transduction cascade controls cellular differentiation in response to nutrients</article-title><source>Molecular Biology of the Cell</source><volume>12</volume><fpage>4103</fpage><lpage>4113</lpage><pub-id pub-id-type="doi">10.1091/mbc.12.12.4103</pub-id><pub-id pub-id-type="pmid">11739804</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Ambrosio</surname><given-names>MV</given-names></name><name><surname>Vale</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A whole genome rnai screen of <italic>Drosophila</italic> S2 cell spreading performed using automated computational image analysis</article-title><source>The Journal of Cell Biology</source><volume>191</volume><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1083/jcb.201003135</pub-id><pub-id pub-id-type="pmid">21041442</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>THW</given-names></name><name><surname>Tao</surname><given-names>R-H</given-names></name><name><surname>Swaminathan</surname><given-names>J</given-names></name><name><surname>Maegawa</surname><given-names>S</given-names></name><name><surname>Shaik</surname><given-names>S</given-names></name><name><surname>Bravo-Alegria</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Kennis</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Callegari</surname><given-names>K</given-names></name><name><surname>Haltom</surname><given-names>AR</given-names></name><name><surname>Taylor</surname><given-names>P</given-names></name><name><surname>Kogiso</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Khatua</surname><given-names>S</given-names></name><name><surname>Goldman</surname><given-names>S</given-names></name><name><surname>Lulla</surname><given-names>RR</given-names></name><name><surname>Fangusaro</surname><given-names>J</given-names></name><name><surname>MacDonald</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>X-N</given-names></name><name><surname>Hawkins</surname><given-names>C</given-names></name><name><surname>Rajaram</surname><given-names>V</given-names></name><name><surname>Gopalakrishnan</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptional repressor rest drives lineage stage-specific chromatin compaction at PTCH1 and increases Akt activation in a mouse model of medulloblastoma</article-title><source>Science Signaling</source><volume>12</volume><elocation-id>565</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aan8680</pub-id><pub-id pub-id-type="pmid">30670636</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewen-Campen</surname><given-names>B</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Accessing the phenotype gap: enabling systematic investigation of paralog functional complexity with CRISPR</article-title><source>Developmental Cell</source><volume>43</volume><fpage>6</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.09.020</pub-id><pub-id pub-id-type="pmid">29017030</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Walther</surname><given-names>TC</given-names></name><name><surname>Rao</surname><given-names>M</given-names></name><name><surname>Stuurman</surname><given-names>N</given-names></name><name><surname>Goshima</surname><given-names>G</given-names></name><name><surname>Terayama</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>JS</given-names></name><name><surname>Vale</surname><given-names>RD</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name><name><surname>Farese</surname><given-names>RV</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Functional genomic screen reveals genes involved in lipid-droplet formation and utilization</article-title><source>Nature</source><volume>453</volume><fpage>657</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1038/nature06928</pub-id><pub-id pub-id-type="pmid">18408709</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutmann</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Grzybek</surname><given-names>M</given-names></name><name><surname>Walz</surname><given-names>T</given-names></name><name><surname>Coskun</surname><given-names>Ü</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor</article-title><source>The Journal of Cell Biology</source><volume>217</volume><fpage>1643</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1083/jcb.201711047</pub-id><pub-id pub-id-type="pmid">29453311</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>L</given-names></name><name><surname>Sakurai</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Sorensen</surname><given-names>E</given-names></name><name><surname>Nidom</surname><given-names>CA</given-names></name><name><surname>Newton</surname><given-names>MA</given-names></name><name><surname>Ahlquist</surname><given-names>P</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title><italic>Drosophila</italic> rnai screen identifies host genes important for influenza virus replication</article-title><source>Nature</source><volume>454</volume><fpage>890</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1038/nature07151</pub-id><pub-id pub-id-type="pmid">18615016</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>R-G</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Ewen-Campen</surname><given-names>B</given-names></name><name><surname>Rajakumar</surname><given-names>R</given-names></name><name><surname>Zirin</surname><given-names>J</given-names></name><name><surname>Yang-Zhou</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Mao</surname><given-names>D</given-names></name><name><surname>Peng</surname><given-names>P</given-names></name><name><surname>Qiao</surname><given-names>H-H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L-P</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Ji</surname><given-names>J-Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Ni</surname><given-names>J-Q</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Next-generation CRISPR/cas9 transcriptional activation in <italic>Drosophila</italic> using flysam</article-title><source>PNAS</source><volume>115</volume><fpage>4719</fpage><lpage>4724</lpage><pub-id pub-id-type="doi">10.1073/pnas.1800677115</pub-id><pub-id pub-id-type="pmid">29666231</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>AR</given-names></name><name><surname>Choi</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tric/Cct chaperonins are essential for organ growth by interacting with insulin/TOR signaling in <italic>Drosophila</italic></article-title><source>Oncogene</source><volume>38</volume><fpage>4739</fpage><lpage>4754</lpage><pub-id pub-id-type="doi">10.1038/s41388-019-0754-1</pub-id><pub-id pub-id-type="pmid">30792539</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konermann</surname><given-names>S</given-names></name><name><surname>Brigham</surname><given-names>MD</given-names></name><name><surname>Trevino</surname><given-names>AE</given-names></name><name><surname>Joung</surname><given-names>J</given-names></name><name><surname>Abudayyeh</surname><given-names>OO</given-names></name><name><surname>Barcena</surname><given-names>C</given-names></name><name><surname>Hsu</surname><given-names>PD</given-names></name><name><surname>Habib</surname><given-names>N</given-names></name><name><surname>Gootenberg</surname><given-names>JS</given-names></name><name><surname>Nishimasu</surname><given-names>H</given-names></name><name><surname>Nureki</surname><given-names>O</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genome-scale transcriptional activation by an engineered CRISPR-cas9 complex</article-title><source>Nature</source><volume>517</volume><fpage>583</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1038/nature14136</pub-id><pub-id pub-id-type="pmid">25494202</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakshmi</surname><given-names>B</given-names></name><name><surname>Mishra</surname><given-names>M</given-names></name><name><surname>Srinivasan</surname><given-names>N</given-names></name><name><surname>Archunan</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structure-Based phylogenetic analysis of the lipocalin superfamily</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0135507</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0135507</pub-id><pub-id pub-id-type="pmid">26263546</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>554</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0554-4</pub-id><pub-id pub-id-type="pmid">25476604</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>SM</given-names></name><name><surname>Fairn</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mesoscale organization of domains in the plasma membrane-beyond the lipid raft</article-title><source>Critical Reviews in Biochemistry and Molecular Biology</source><volume>53</volume><fpage>192</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1080/10409238.2018.1436515</pub-id><pub-id pub-id-type="pmid">29457544</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>D</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Che</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L-P</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>J-Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Enhanced efficiency of flysam by optimization of sgRNA parameters in <italic>Drosophila</italic></article-title><source>G3: Genes, Genomes, Genetics</source><volume>10</volume><fpage>4483</fpage><lpage>4488</lpage><pub-id pub-id-type="doi">10.1534/g3.120.401614</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariyappa</surname><given-names>D</given-names></name><name><surname>Rusch</surname><given-names>DB</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Luhur</surname><given-names>A</given-names></name><name><surname>Overton</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>DFB</given-names></name><name><surname>Bergman</surname><given-names>CM</given-names></name><name><surname>Zelhof</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A novel transposable element-based authentication protocol for <italic>Drosophila</italic> cell lines</article-title><source>G3: Genes, Genomes, Genetics</source><volume>12</volume><elocation-id>jkab403</elocation-id><pub-id pub-id-type="doi">10.1093/g3journal/jkab403</pub-id><pub-id pub-id-type="pmid">34849844</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumüller</surname><given-names>RA</given-names></name><name><surname>Wirtz-Peitz</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>Y</given-names></name><name><surname>Buckner</surname><given-names>M</given-names></name><name><surname>Hoskins</surname><given-names>RA</given-names></name><name><surname>Venken</surname><given-names>KJT</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stringent analysis of gene function and protein-protein interactions using fluorescently tagged genes</article-title><source>Genetics</source><volume>190</volume><fpage>931</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.136465</pub-id><pub-id pub-id-type="pmid">22174071</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reikvam</surname><given-names>H</given-names></name><name><surname>Tamburini</surname><given-names>J</given-names></name><name><surname>Skrede</surname><given-names>S</given-names></name><name><surname>Holdhus</surname><given-names>R</given-names></name><name><surname>Poulain</surname><given-names>L</given-names></name><name><surname>Ersvaer</surname><given-names>E</given-names></name><name><surname>Hatfield</surname><given-names>KJ</given-names></name><name><surname>Bruserud</surname><given-names>Ø</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal Cdc25B expression as determinate of pharmacological effect</article-title><source>British Journal of Haematology</source><volume>164</volume><fpage>200</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1111/bjh.12611</pub-id><pub-id pub-id-type="pmid">24383842</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiling</surname><given-names>JH</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in <italic>Drosophila</italic></article-title><source>Genes &amp; Development</source><volume>18</volume><fpage>2879</fpage><lpage>2892</lpage><pub-id pub-id-type="doi">10.1101/gad.322704</pub-id><pub-id pub-id-type="pmid">15545626</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Replogle</surname><given-names>JM</given-names></name><name><surname>Norman</surname><given-names>TM</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name><name><surname>Hussmann</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cogan</surname><given-names>JZ</given-names></name><name><surname>Meer</surname><given-names>EJ</given-names></name><name><surname>Terry</surname><given-names>JM</given-names></name><name><surname>Riordan</surname><given-names>DP</given-names></name><name><surname>Srinivas</surname><given-names>N</given-names></name><name><surname>Fiddes</surname><given-names>IT</given-names></name><name><surname>Arthur</surname><given-names>JG</given-names></name><name><surname>Alvarado</surname><given-names>LJ</given-names></name><name><surname>Pfeiffer</surname><given-names>KA</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name><name><surname>Adamson</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing</article-title><source>Nature Biotechnology</source><volume>38</volume><fpage>954</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0470-y</pub-id><pub-id pub-id-type="pmid">32231336</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez</surname><given-names>Y</given-names></name><name><surname>Unno</surname><given-names>K</given-names></name><name><surname>Truica</surname><given-names>MI</given-names></name><name><surname>Chalmers</surname><given-names>ZR</given-names></name><name><surname>Yoo</surname><given-names>YA</given-names></name><name><surname>Vatapalli</surname><given-names>R</given-names></name><name><surname>Sagar</surname><given-names>V</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Lysy</surname><given-names>B</given-names></name><name><surname>Hussain</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Abdulkadir</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A genome-wide CRISPR activation screen identifies PRRX2 as A regulator of enzalutamide resistance in prostate cancer</article-title><source>Cancer Research</source><volume>82</volume><fpage>2110</fpage><lpage>2123</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-21-3565</pub-id><pub-id pub-id-type="pmid">35405009</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanjana</surname><given-names>NE</given-names></name><name><surname>Shalem</surname><given-names>O</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Improved vectors and genome-wide libraries for CRISPR screening</article-title><source>Nature Methods</source><volume>11</volume><fpage>783</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3047</pub-id><pub-id pub-id-type="pmid">25075903</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scapin</surname><given-names>G</given-names></name><name><surname>Dandey</surname><given-names>VP</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Prosise</surname><given-names>W</given-names></name><name><surname>Hruza</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>T</given-names></name><name><surname>Mayhood</surname><given-names>T</given-names></name><name><surname>Strickland</surname><given-names>C</given-names></name><name><surname>Potter</surname><given-names>CS</given-names></name><name><surname>Carragher</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis</article-title><source>Nature</source><volume>556</volume><fpage>122</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/nature26153</pub-id><pub-id pub-id-type="pmid">29512653</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmelzle</surname><given-names>T</given-names></name><name><surname>Beck</surname><given-names>T</given-names></name><name><surname>Martin</surname><given-names>DE</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Activation of the RAS/cyclic AMP pathway suppresses a TOR deficiency in yeast</article-title><source>Molecular and Cellular Biology</source><volume>24</volume><fpage>338</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.1.338-351.2004</pub-id><pub-id pub-id-type="pmid">14673167</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scuderi</surname><given-names>A</given-names></name><name><surname>Simin</surname><given-names>K</given-names></name><name><surname>Kazuko</surname><given-names>SG</given-names></name><name><surname>Metherall</surname><given-names>JE</given-names></name><name><surname>Letsou</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Scylla and charybde, homologues of the human apoptotic gene RTP801, are required for head involution in <italic>Drosophila</italic></article-title><source>Developmental Biology</source><volume>291</volume><fpage>110</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.12.014</pub-id><pub-id pub-id-type="pmid">16423342</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofer</surname><given-names>S</given-names></name><name><surname>Lamkiewicz</surname><given-names>K</given-names></name><name><surname>Armoza Eilat</surname><given-names>S</given-names></name><name><surname>Partouche</surname><given-names>S</given-names></name><name><surname>Marz</surname><given-names>M</given-names></name><name><surname>Moskovits</surname><given-names>N</given-names></name><name><surname>Stemmer</surname><given-names>SM</given-names></name><name><surname>Shlomai</surname><given-names>A</given-names></name><name><surname>Sklan</surname><given-names>EH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A genome-wide CRISPR activation screen reveals hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells</article-title><source>FASEB Journal</source><volume>36</volume><elocation-id>e22191</elocation-id><pub-id pub-id-type="doi">10.1096/fj.202101507RR</pub-id><pub-id pub-id-type="pmid">35147243</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Mizrak</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Cicconet</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>ZW</given-names></name><name><surname>Tang</surname><given-names>WC</given-names></name><name><surname>Lu</surname><given-names>CH</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Farese</surname><given-names>RV</given-names></name><name><surname>Walther</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Identification of two pathways mediating protein targeting from ER to lipid droplets</article-title><source>Nature Cell Biology</source><volume>24</volume><fpage>1364</fpage><lpage>1377</lpage><pub-id pub-id-type="doi">10.1038/s41556-022-00974-0</pub-id><pub-id pub-id-type="pmid">36050470</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sopko</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>YB</given-names></name><name><surname>Makhijani</surname><given-names>K</given-names></name><name><surname>Alexander</surname><given-names>B</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Brückner</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A systems-level interrogation identifies regulators of <italic>Drosophila</italic> blood cell number and survival</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005056</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005056</pub-id><pub-id pub-id-type="pmid">25749252</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stapleton</surname><given-names>M</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Brokstein</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Champe</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>R</given-names></name><name><surname>Guarin</surname><given-names>H</given-names></name><name><surname>Kronmiller</surname><given-names>B</given-names></name><name><surname>Pacleb</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Wan</surname><given-names>K</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Celniker</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A <italic>Drosophila</italic> full-length cdna resource</article-title><source>Genome Biology</source><volume>3</volume><elocation-id>RESEARCH0080</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2002-3-12-research0080</pub-id><pub-id pub-id-type="pmid">12537569</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suresh</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>WT</given-names></name><name><surname>London</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Phospholipid exchange shows insulin receptor activity is supported by both the propensity to form wide bilayers and ordered raft domains</article-title><source>The Journal of Biological Chemistry</source><volume>297</volume><elocation-id>101010</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2021.101010</pub-id><pub-id pub-id-type="pmid">34324831</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>C</given-names></name><name><surname>Fiandalo</surname><given-names>MV</given-names></name><name><surname>Pop</surname><given-names>E</given-names></name><name><surname>Stocking</surname><given-names>JJ</given-names></name><name><surname>Azabdaftari</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name><name><surname>Mohler</surname><given-names>JL</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Proteomic analysis of charcoal-stripped fetal bovine serum reveals changes in the insulin-like growth factor signaling pathway</article-title><source>Journal of Proteome Research</source><volume>17</volume><fpage>2963</fpage><lpage>2977</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00135</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viswanatha</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pooled genome-wide CRISPR screening for basal and context-specific fitness gene essentiality in <italic>Drosophila</italic> cells</article-title><source>eLife</source><volume>7</volume><elocation-id>e36333</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.36333</pub-id><pub-id pub-id-type="pmid">30051818</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walton</surname><given-names>RT</given-names></name><name><surname>Christie</surname><given-names>KA</given-names></name><name><surname>Whittaker</surname><given-names>MN</given-names></name><name><surname>Kleinstiver</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Unconstrained genome targeting with near-pamless engineered CRISPR-Cas9 variants</article-title><source>Science</source><volume>368</volume><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1126/science.aba8853</pub-id><pub-id pub-id-type="pmid">32217751</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A comparative analysis of divergently-paired genes (DPGs) among <italic>Drosophila</italic> and vertebrate genomes</article-title><source>BMC Evolutionary Biology</source><volume>9</volume><elocation-id>55</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2148-9-55</pub-id><pub-id pub-id-type="pmid">19284596</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Wan</surname><given-names>KH</given-names></name><name><surname>Hammonds</surname><given-names>AS</given-names></name><name><surname>Stapleton</surname><given-names>M</given-names></name><name><surname>Carlson</surname><given-names>JW</given-names></name><name><surname>Celniker</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Development of expression-ready constructs for generation of proteomic libraries</article-title><source>Methods in Molecular Biology</source><volume>723</volume><fpage>257</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-043-0_17</pub-id><pub-id pub-id-type="pmid">21370071</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Yau</surname><given-names>E</given-names></name><name><surname>Hui</surname><given-names>H</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>Achuthan</surname><given-names>V</given-names></name><name><surname>Young Karris</surname><given-names>MA</given-names></name><name><surname>Engelman</surname><given-names>AN</given-names></name><name><surname>Rana</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Genome-wide crispr/cas9 transcriptional activation screen identifies a histone acetyltransferase inhibitor complex as a regulator of hiv-1 integration</article-title><source>Nucleic Acids Research</source><volume>50</volume><fpage>6687</fpage><lpage>6701</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac464</pub-id><pub-id pub-id-type="pmid">35713529</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Du</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Genome-Wide CRISPR activation screen identifies candidate receptors for SARS-cov-2 entry</article-title><source>Science China Life Sciences</source><volume>65</volume><fpage>701</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1007/s11427-021-1990-5</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zidovetzki</surname><given-names>R</given-names></name><name><surname>Levitan</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies</article-title><source>Biochimica et Biophysica Acta</source><volume>1768</volume><fpage>1311</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2007.03.026</pub-id><pub-id pub-id-type="pmid">17493580</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zurita-Martinez</surname><given-names>SA</given-names></name><name><surname>Cardenas</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Tor and cyclic AMP-protein kinase A: two parallel pathways regulating expression of genes required for cell growth</article-title><source>Eukaryotic Cell</source><volume>4</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1128/EC.4.1.63-71.2005</pub-id><pub-id pub-id-type="pmid">15643061</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85542.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ht1xw27</institution-id><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.12.09.519790" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.09.519790"/></front-stub><body><p>This work is well-structured, with clear objectives and experiments. The authors successfully demonstrated genome-wide gene activation which overcame previous failed attempts to replicate gene activation that worked well in mammalian systems. The study is detailed and relevant for the application of CRISPRa in understanding the function of candidate genes.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85542.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ht1xw27</institution-id><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Padinjat</surname><given-names>Raghu</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03gf8rp76</institution-id><institution>National Centre for Biological Sciences</institution></institution-wrap><country>India</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.09.519790">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.12.09.519790v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Pooled genome-wide CRISPR activation screening for rapamycin resistance genes in <italic>Drosophila</italic> cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Raghu Padinjat (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. As you can see, the suggestions for revision are readily addressable. We look forward to receiving a revised manuscript speedily.</p><p>Essential revisions:</p><p>While we strongly recommend this manuscript for publication some corrections and revisions are listed.</p><p>1. The authors used attP cells to integrate sgRNA, and it would be useful to know the copy number of attP sites per cell and whether the cells are homogeneous. If this information is available, it should be added to the manuscript.</p><p>2. Due to the inherent nature of the metallothionein promoter, the authors observed significant leaky activation. While this may not be an issue while studying the rapamycin pathway, it could be problematic when studying sensitive signaling processes. Therefore, a clear disclaimer should be added to the discussion.</p><p>3. The manuscript demonstrates that CRISPRa is specific and does not activate neighboring genes with just a single example. However, it is possible that insulator sequences protect neighboring gene activation in this case. Therefore, the authors should either show more examples to demonstrate this convincingly or explicitly state this in the discussion.</p><p>4. It would be helpful to know the abundance of gRNA in the library compared to the hits identified in the screen. Was there a greater probability of a target showing up as positive in the screen when its abundance is overrepresented in the library?</p><p>5. The authors may want to speculate as to why Cyp12a4 did not come up on the second screen.</p><p>6. It would be useful to know whether p-Akt was checked in CG9932 knockdown and why it was excluded from the experiment.</p><p>7. The experiments to suggest insulin-independent activation of InR by CG5399 require more conclusive experiments. Serum starvation is not sufficient to conclusively state this, and the authors should discuss this limitation.</p><p>8. The discussion lacks clarity and focus, particularly in the second paragraph. Instead, the authors could focus on the tools generated in the article and compare and discuss similar tools available in other model systems. They could also speculate on how such a tool in a <italic>Drosophila</italic> model will serve in new research questions.</p><p>9. Although the work seems more focused on generating a fly tool for CRISPRa, there are some nice discoveries of new functions for some of the fly genes. This could be better illustrated with a model showing signaling pathways and highlighting the gene functions identified in this study. It would be helpful to include an overall description of the InK-AktmTOR pathway with only major signaling cascade molecules for understanding.</p><p>10. It is recommended to expand abbreviations at their first mention. For example, the full form of InR should be included in Line 51.</p><p>11. It would be helpful to briefly explain the role of each component of the SAM complex- VP64, MS2, p65, and HSF1 for a better understanding of the use of the SAM complex.</p><p>12. In Line 100 and in a few parts of the same section, it is unclear what &quot;cell fitness&quot; indicates. It would be useful to specify whether it refers to cell viability, proliferation rate, or cell functionality and what parameters were measured to assess fitness.</p><p>13. In Line 124, the authors should state the rationale for including non-coding genes in the study with respect to rapamycin resistance. Were any non-coding targets identified in the screen?</p><p>14. The details of the software used for statistical analysis are missing. The details of FACS, its gating, and control parameters could be added.</p><p>15. In general, the legends for the figures could be better explained in detail. Eg: Appropriate statistical explanations for * needed wherever mentioned in figures. Abbreviations in plasmid constructs needed better explanations.</p><p>16. Authors have taken a number of measures to maintain the integrity of the CRISPRa library, including multiple gRNA targets per gene, 1000 cells per gRNA, and deep sequencing. However, do the authors have an idea of what percentage of the gRNA vectors are functional? Looking at the data they show for the 3 candidate genes, at least half of them are not functional, which could be either because of gRNA location or efficiency. Considering this to be an average situation, there might be a large number of genes for which all gRNAs might not function at all. We understand this might be a caveat for all such studies, but an estimate of some kind in discussion might be useful for anyone who might want to use these resources.</p><p>17. As the authors mention that ~32% of genes in <italic>Drosophila</italic> have transcription start sites &lt;1kb apart, off-targeting (neighboring genes getting activated in addition to the intended gene) will be an issue. To address this, the authors describe one example of genes where although the genes TSS are within one kb of each other, the sgRNA specifically activated only one gene and not the other. However, since following this, authors have generated genome-wide resources keeping 500bp upstream as their benchmark, a large percentage of these 32% genes might have off-targets. It would be useful to know the estimates of off-targeting for such a resource. In addition, have authors looked at the transcripts of genes close to the specific genes they have studied? CG9932 is in close proximity to (although not within the 1 kb range) a few genes including mTOR.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85542.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>While we strongly recommend this manuscript for publication some corrections and revisions are listed.</p><p>1. The authors used attP cells to integrate sgRNA, and it would be useful to know the copy number of attP sites per cell and whether the cells are homogeneous. If this information is available, it should be added to the manuscript.</p></disp-quote><p>The <italic>attP</italic> sites containing S2R+ derivative PT5 cell line used in this study has been described in our previous publication (PMID: 22174071). The <italic>attP</italic> cassette was inserted into the genome by MiMIC transposition. The PT5 cell line was established from a single cell-derived clone after MiMIC transposon insertion and the insertion site was mapped to the <italic>Clic</italic> locus by inverse PCR. We have added this information to the manuscript.</p><disp-quote content-type="editor-comment"><p>2. Due to the inherent nature of the metallothionein promoter, the authors observed significant leaky activation. While this may not be an issue while studying the rapamycin pathway, it could be problematic when studying sensitive signaling processes. Therefore, a clear disclaimer should be added to the discussion.</p></disp-quote><p>We agree that the leaky expression from the metallothionein promoter might be an issue for some applications. We have added the following text to the discussion: “In our method, the synthetic transcriptional activators of the SAM complex (dCas9-VP64 and MCP-p65-HSF1) are driven by the metallothionein promoter. Due to the leaky expression of this promoter, we observed moderate gene activation without copper induction. Availability of a tighter controlled promoter may be required for more sensitive screens.”</p><disp-quote content-type="editor-comment"><p>3. The manuscript demonstrates that CRISPRa is specific and does not activate neighboring genes with just a single example. However, it is possible that insulator sequences protect neighboring gene activation in this case. Therefore, the authors should either show more examples to demonstrate this convincingly or explicitly state this in the discussion.</p></disp-quote><p>We did not systematically analyze the collateral activation of neighboring genes in our study. However, previous work from others (PMID: 33020192) have shown that sgRNAs targeting areas beyond -600 bp from the TSS lose efficiency in <italic>Drosophila</italic>, which may alleviate the concern of collateral activation of neighboring genes when the sgRNAs are over 600 bp away. We have added the following text to the discussion: “As the <italic>Drosophila</italic> genome is relatively compact, one concern for CRIPRa is collateral activation of adjacent genes. Previous work has shown that sgRNAs targeting areas beyond -600 bp from the TSS in <italic>Drosophila</italic> lose efficiency (PMID: 33020192), which may alleviate the concern of collateral activation when the sgRNAs target sites are over 600 bp away from the TSS of neighboring genes.”</p><disp-quote content-type="editor-comment"><p>4. It would be helpful to know the abundance of gRNA in the library compared to the hits identified in the screen. Was there a greater probability of a target showing up as positive in the screen when its abundance is overrepresented in the library?</p></disp-quote><p>That is not the case. We ranked sgRNAs based on their abundance in the initial population and highlighted sgRNAs of the top three hits from the rapamycin screen. The sgRNAs of the top hits are not overrepresented in the initial population. In fact, the hits are identified by the change of the sgRNAs in the Rapamycin treated population compared to DMSO treated population. It is not related to the sgRNA abundance in the initial population.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Reads of <italic>CG5399</italic> sgRNAs in the initial population (<italic>CG5399</italic> sgRNAs are in red, other sgRNAs are in gray).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-sa2-fig1-v1.tif"/></fig><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Reads of <italic>CG8468</italic> sgRNAs in the initial population (<italic>CG8468</italic> sgRNAs are in red, other sgRNAs are in gray).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-sa2-fig2-v1.tif"/></fig><fig id="sa2fig3" position="float"><label>Author response image 3.</label><caption><title>Reads of <italic>CG9932</italic> sgRNAs in the initial population (<italic>CG9932</italic> sgRNAs are in red, other sgRNAs are in gray).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85542-sa2-fig3-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>5. The authors may want to speculate as to why Cyp12a4 did not come up on the second screen.</p></disp-quote><p><italic>Cyp12a4</italic> was identified as a hit affecting cell fitness from the screen with the focused library but was not identified from the screen with the genome-wide library. There are ~10 sgRNA vectors per gene in the focused library while ~ 6 sgRNA vectors per gene in the genome-wide library. We speculate that the sgRNA vector number per gene in different libraries might affect the power to identify some hits. It suggests that a next generation CRISPRa library should include more sgRNA vectors per gene.</p><disp-quote content-type="editor-comment"><p>6. It would be useful to know whether p-Akt was checked in CG9932 knockdown and why it was excluded from the experiment.</p></disp-quote><p>Previous work has shown that overexpression of <italic>REST</italic>, the human ortholog of <italic>CG9932</italic>, activates Akt (PMID: 30670636). As it is consistent with what we observed in fly cells, we did not follow up with the characterization of <italic>CG9932</italic>.</p><disp-quote content-type="editor-comment"><p>7. The experiments to suggest insulin-independent activation of InR by CG5399 require more conclusive experiments. Serum starvation is not sufficient to conclusively state this, and the authors should discuss this limitation.</p></disp-quote><p>In this study, we observed InR activation by <italic>CG5399</italic> overexpression without insulin treatment, and all the experiments were done without insulin stimulation. <italic>Drosophila</italic> cells are cultured in Schneider medium supplemented with 10% FBS (fetal bovine serum). The Schneider medium only consists of amino acids and inorganic salts while FBS is a biological product which might contain trace amount of insulin and insulin-like growth factors (PMID: 30014700). To further exclude the effect of insulin and insulin-like growth factors in FBS, we removed FBS from the culture medium. We have added this information to the manuscript to clarify the design of the serum starvation experiment.</p><disp-quote content-type="editor-comment"><p>8. The discussion lacks clarity and focus, particularly in the second paragraph. Instead, the authors could focus on the tools generated in the article and compare and discuss similar tools available in other model systems. They could also speculate on how such a tool in a <italic>Drosophila</italic> model will serve in new research questions.</p></disp-quote><p>We have modified our discussion. We deleted the original second paragraph and added a discussion on the limitations of our current CRISPRa system and the design of next generation CRISPRa system.</p><disp-quote content-type="editor-comment"><p>9. Although the work seems more focused on generating a fly tool for CRISPRa, there are some nice discoveries of new functions for some of the fly genes. This could be better illustrated with a model showing signaling pathways and highlighting the gene functions identified in this study. It would be helpful to include an overall description of the InK-AktmTOR pathway with only major signaling cascade molecules for understanding.</p></disp-quote><p>We have added a schematic model of InR-Akt-mTOR activation in <italic>CG5399</italic> overexpressing cells to Figure 4—figure supplement 1E.</p><disp-quote content-type="editor-comment"><p>10. It is recommended to expand abbreviations at their first mention. For example, the full form of InR should be included in Line 51.</p></disp-quote><p>We have added the full name of RTK in Line 49 and the full name of InR in the abstract.</p><disp-quote content-type="editor-comment"><p>11. It would be helpful to briefly explain the role of each component of the SAM complex- VP64, MS2, p65, and HSF1 for a better understanding of the use of the SAM complex.</p></disp-quote><p>We have added the following text to the manuscript to describe the role of each component of the SAM complex: “VP64, p65 and HSF1 are transcriptional activators while the MS2 coat protein recognizes and binds to MS2 hairpins present in the sgRNAs, recruiting the fused transcriptional activators to gene promoters targeted by sgRNAs.”</p><disp-quote content-type="editor-comment"><p>12. In Line 100 and in a few parts of the same section, it is unclear what &quot;cell fitness&quot; indicates. It would be useful to specify whether it refers to cell viability, proliferation rate, or cell functionality and what parameters were measured to assess fitness.</p></disp-quote><p>As the readout is the sgRNA abundance in the final population, cell fitness in this study is a combined effect from cell viability, proliferation rate and cell functionality.</p><disp-quote content-type="editor-comment"><p>13. In Line 124, the authors should state the rationale for including non-coding genes in the study with respect to rapamycin resistance. Were any non-coding targets identified in the screen?</p></disp-quote><p>As we wanted to establish a universal platform for the <italic>Drosophila</italic> community, the genome wide library design also includes non-coding genes for a broader application. One non-coding gene (<italic>CR44587</italic>) was identified as a hit affecting cell fitness (Table 1) and another non-coding gene (<italic>CR43417</italic>) was identified as a hit conferring rapamycin resistance in one replicate of the screen (Figure 2B).</p><disp-quote content-type="editor-comment"><p>14. The details of the software used for statistical analysis are missing. The details of FACS, its gating, and control parameters could be added.</p></disp-quote><p>For the software used for statistical analysis, we have added the following text to the Materials and methods: “The statistical analysis was perfomed using the GraphPad Prism 7 software.” For the FACS and gating, we have added the following text to the Materials and methods: “Cells were transferred into 5 mL FACS tubes (Falcon 352235) and analyzed with a BD LSR II Flow Cytometer in the Department of Immunology Flow Cytometry Facility, Harvard Medical School. Wildtype cells (GFP negative cells) and empty vector expressing cells (GFP positive cells) were used as negative and positive control to set the gate in Alexa Fluor 488 channel, respectively. With this gate, the GFP proportion in wildtype cells is 0.031% and in empty vector expressing cells is 96.7%. Three biological replicates for each condition were tested. The flow cytometry files were analyzed by Flowjo. The statistical analysis was performed using the GraphPad Prism 7 software. t-tests were performed to test the significance of GFP proportion data. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; ns, not significant.”</p><disp-quote content-type="editor-comment"><p>15. In general, the legends for the figures could be better explained in detail. Eg: Appropriate statistical explanations for * needed wherever mentioned in figures. Abbreviations in plasmid constructs needed better explanations.</p></disp-quote><p>We have added the statistical analysis used in each figure. We have added the following text to the figure 1A legend: “dCas9-VP64 and MCP-p65-HSF1 were expressed as T2A-containing bicistronic transcript. sgRNA was expressed from pLib8 plasmid, which contains a <italic>attB</italic> flanking GFP-T2A-PuroR cassette for <italic>attP</italic> sites recombination.”</p><disp-quote content-type="editor-comment"><p>16. Authors have taken a number of measures to maintain the integrity of the CRISPRa library, including multiple gRNA targets per gene, 1000 cells per gRNA, and deep sequencing. However, do the authors have an idea of what percentage of the gRNA vectors are functional? Looking at the data they show for the 3 candidate genes, at least half of them are not functional, which could be either because of gRNA location or efficiency. Considering this to be an average situation, there might be a large number of genes for which all gRNAs might not function at all. We understand this might be a caveat for all such studies, but an estimate of some kind in discussion might be useful for anyone who might want to use these resources.</p></disp-quote><p>Previous CRISPRa studies have shown that activation efficiency is affected by the basal expression level and epigenetic state of target genes (PIMD: 25494202, 36917981). Moreover, for the same genes, we observed that some sgRNA vectors can activate target genes while others cannot (Figure 2f and 2I). In our original manuscript, we speculated that this is possibly due to steric hindrance by pre-existing proteins in the promoter regions, or due to different sgRNA binding efficiency, which can be further optimized in the future by applying machine learning to large screen datasets. Although we do not know how many sgRNAs are functional in the library, it is worth noting that while some sgRNA vectors fail to activate CG5399 and CG9932, these two genes can still be identified as top hits by MAGeCK-RRA analysis. Next generation CRISPRa sgRNA library should include more sgRNA vectors per gene to overcome the inefficient activation of some sgRNAs. We have added the following text to the discussion: “Currently in our CRISPRa system, spCas9 requires NGG as protospacer-adjacent motif (PAM) sequence, which limits sgRNA design in the small region upstream of TSS, especially for closely spaced genes. Next generation CRISPRa system could use PAMless Cas9 variants to remove the PAM constraint for sgRNA design, allowing the construction of libraries with more sgRNAs per gene.”</p><disp-quote content-type="editor-comment"><p>17. As the authors mention that ~32% of genes in <italic>Drosophila</italic> have transcription start sites &lt;1kb apart, off-targeting (neighboring genes getting activated in addition to the intended gene) will be an issue. To address this, the authors describe one example of genes where although the genes TSS are within one kb of each other, the sgRNA specifically activated only one gene and not the other. However, since following this, authors have generated genome-wide resources keeping 500bp upstream as their benchmark, a large percentage of these 32% genes might have off-targets. It would be useful to know the estimates of off-targeting for such a resource. In addition, have authors looked at the transcripts of genes close to the specific genes they have studied? CG9932 is in close proximity to (although not within the 1 kb range) a few genes including mTOR.</p></disp-quote><p>When we designed the genome-wide sgRNA library, if a sgRNA is located within 500 bp upstream of two genes, both genes are annotated as the target genes of the sgRNA. In our genome-wide sgRNAs, 14% of sgRNA vectors are annotated to target more than one gene. In the original manuscript, we discussed that if the hits from the screen form closely spaced divergent gene pairs, more experiments will be required to identify which one contributes to the phenotype. We have also added some discussion to the manuscript about next generation sgRNA library with closer space to target gene using PAMless Cas9 variants. For <italic>CG8468</italic>, <italic>CG5399</italic> and <italic>CG9932</italic>, none of them form divergent gene pairs with neighboring genes within 1 kb. <italic>CG9932</italic> is over 50 kb away from mTOR, sgRNAs targeting <italic>CG9932</italic> are unlikely to active mTOR according to the previous study (PMID: 33020192). Moreover, for <italic>CG5399</italic>, we have excluded the off-target effect of sgRNAs by dsRNA and ORF overexpression.</p></body></sub-article></article>